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Mcl-1 Myeloid cell leukemia sequence 1 
MCU Mitochondrial Calcium Uniporter 
MEF Mouse embryonic fibroblast 
MFN1/2 Mitofusin 1/2 
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∆Ψm Mitochondrial membrane potential 
MS Multiple sclerosis 
MTCO1 Mitochondrially encoded cytochrome c oxidase I 
NADH Nicotinamide adenine dinucleotide 
NCX Sodium Calcium exchanger 
NDUF8B NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8 
NG2 Chondroitin sulfate proteoglycan NG2 
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OMM Outer mitochondrial membrane 
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Abstract 
 
In recent years, mitochondria have gained much interest as organelles involved not only in the 
processes of obtaining energy, but also associated with novel roles in cell physiopathology. These 
roles range from mitochondria being the site for lipid synthesis, through  constituting a buffering 
system for intracellular calcium, and from being a mediator of reactive oxygen species signalling to 
a regulator of different cell death types. This group of roles requires a highly regulated system of 
signalling mechanisms. One of these emerging mechanisms is the communication between the 
mitochondria and the endoplasmic reticulum. In fact, mitochondria and endoplasmic reticulum are 
tightly associated, in a region called mitochondria associated membranes, where several signalling 
events allow continuous communication between the two organelles. Among these signalling 
events, calcium signalling has been considered of great importance. Advanced techniques of 
molecular biology allow the development of tools for the investigation of these complex subcellular 
compartments. Particularly useful are those based on the green fluorescent protein and the calcium 
sensitive luminescent protein, aequorin. 
In this work, the aforementioned tools have been used to investigate mitochondrial physiology, 
especially its communications with the endoplasmic reticulum. Two different cellular events were 
studied: i) the regulation of apoptosis by a strategic oncosuppressor, p53 and ii) differentiation of 
oligodendrocytes progenitor cells into adult oligodendrocytes during stress condition generated by 
cytokines. 
Performed experiments allowed the describing of the endoplasmic reticulum as a new intracellular 
localization site of p53, where it increases the luminal calcium concentration, promoting the 
sensitivity to calcium dependent apoptotic stimuli. Simultaneously, it has been revealed how 
mitochondria are a target for TNFα in oligodendrocytes progenitors, where it promotes reactive 
oxygen species production and impairment of the respiratory chain activity, inhibiting cell 
differentiation without promoting cell death.In conclusion, these approaches reveal completely new 
relations between mitochondria, calcium signalling and cell physiology, shedding new light on the 
role for this fascinating organelle. 
 
 
 
 
 
 
 
 7 
  
 8 
Riassunto 
 
I mitocondri, sebbene da sempre considerati la principale sorgente energetica intracellulare, negli 
ultimi anni sono stati sempre più investiti di ruoli completamente nuovi per la patofisiologia 
cellulare. Questi vanno dalla sintesi dei lipidi, a sistema di buffer intracellulare del calcio, da 
mediatori della segnalazione via ROS a regolatore di vari meccanismi di morte intracellulare. 
Questo insieme di ruoli richiedono un regolato sistema di vie di segnalazione, di cui una delle 
emergenti, è la comunicazione con il reticolo endoplasmatico. Infatti mitocondri e reticolo 
endoplasmatico sono strettamente associate, in quella regione chiamata MAM, dove diversi eventi 
segnalatori avvengono permettendo una comunicazione continua tra I due organelli, primo fra tutti 
la segnalazione via calcio. Le recenti tecniche di biologia molecolare hanno permesso lo sviluppo di 
strumenti per lo studio di questi complessi sottodistretti cellulari, in modo particolare basati sulla 
proteina fluorescente verde e sulla sonda luminescente calcio-sensibile equorina. 
In questo lavoro tali strumenti sono stati usati per studiare la fisiologia mitocondriale,  specialmente 
le sue comunicazioni con il reticolo endoplasmico, in due eventi cellulari completamente diversi: la 
regolazione dell’apoptosi da parte dell’oncosoppressore, p53, e il differenziamento da progenitore 
dell’oligodendrocita ad oligodendrocita durante esposizione a citochine proinfiammatorie. 
In particolare questi strumenti ci hanno permesso di osservare come il reticolo endoplasmico debba 
essere considerata una nuova localizzazione intracellulare di p53, dove aumenta la concentrazione 
di calcio intraluminale, promuovendo la sensibilità a stimoli apoptotici calcio dipendenti. 
Contemporaneamente si è ossevato come I mitocondri siano un target del TNFα nei progenitori, 
inducendo un’aumento di ROS e deregolazione della catena respiratoria , con conseguente arresto 
del differenziamento cellulare. 
Concludendo tali approcci hanno permesso di rivelare relazioni completamente nuove tra 
mitocondri, segnalazione via calcio e fisiologia cellulare, sottolineando il ruolo di questo organello 
nella fisiopatologia cellulare. 
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Introduction 
 
Mitochondrial structure 
Mitochondria are organelles with extremely complex structures and functions. They are derived 
from an α-proteobacterium-like ancestor, due to an ancient “invasion” that occurred more than a 
billion years ago (1). The acquisition of mitochondria (and plastids) was a key event in the 
evolution of the eukaryotic cell, supplying it with bioenergetic and biosynthetic factors. 
At subcellular resolution it appear composed by an outer membrane (OMM), mostly permeable to 
ions and metabolites up to 10 kDa, then an highly selective inner mitochondrial membrane (IMM), 
characterized by invaginations called cristae and which enclose the mitochondrial matrix. The space 
between these two structures is traditionally called the intermembrane space (IMS). The IMM is 
further subdivided into two distinct compartments: the peripheral inner boundary membrane and the 
cristae (2). Cristae are not simply random folds, but rather internal compartments formed by 
profound invaginations originating from very tiny “point-like structures” in the inner membrane. 
These narrow tubular structures, called cristae junctions, can limit the diffusion of molecules from 
the intra-cristae space towards the IMS, thus creating a microenvironment where mitochondrial 
electron transport chain (ETC) complexes (as well as other proteins) are hosted and protected from 
random diffusion. The inner boundary membrane is enriched with structural proteins and 
components of the import machinery of mitochondria (3). 
Mitochondrial morphology in living cells is heterogeneous and can range from small spheres to 
interconnected tubules (4). This heterogeneity results from the balance between fusion and fission, 
and represents a process termed mitochondrial dynamics (5). Growing evidence indicates that 
mitochondrial morphology is critical for the physiology of the cell and changes in mitochondrial 
shape have been related to many different processes such as development, neurodegeneration, 
calcium (Ca2+) signalling, ROS production, cell division, and apoptotic cell death (6).  
Mitochondrial shape is controlled by the recently identified “mitochondria-shaping proteins”, which 
regulate the fusion-fission equilibrium of the organelle.  In mammals, key components of the fusion 
machinery include the homologues MFN1 and MFN2 (7). The only dynamin-like GTPase currently 
identified in the IMM is OPA1, a fusion protein which is mutated in dominant optic atrophy 
(DOA), the most common cause of inherited optic neuropathy. Post-transcriptional mechanisms, 
including proteolytic processing, tightly regulate OPA1 activity. In mammalian cells, mitochondrial 
division is regulated by DRP1 and FIS1 (8, 9). The large GTPase DRP1 is a cytosolic dynamin-
related protein whose inhibition or downregulation results in a highly interconnected mitochondrial 
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network (9). The same phenotype is caused by downregulation of FIS1 (8), a protein of the OMM, 
proposed to act as a mitochondrial receptor for DRP1 (10). For example, mitochondrial dynamics 
seem to influence production of ROS and cellular longevity. DRP1-dependent fragmentation of the 
mitochondrial reticulum is a crucial component for accumulation of ROS in pathological conditions 
(11). How mitochondrial fission is required for ROS production and lifespan remains unclear, 
although a link between the two processes seems plausible. Hence, factors other than mitochondrial 
metabolism per se could have a role in the pathogenesis of ROS-related diseases (11).  
Interestingly, many ROS (as well as Reactive Nitrogen Species, RNS) sources and targets are 
localized in the mitochondria or ER and are relevant for different pathways (12). 
 
Mitochondria are the site for major energy production 
Within cells, energy is provided by oxidation of “metabolic fuels” such as carbohydrates, lipids and 
proteins. It is then used to sustain energy-dependent processes, such as the synthesis of 
macromolecules, muscle contraction, active ion transport or thermogenesis. The oxidation process 
results in free energy production that can be stored in phosphoanhydrine “high-energy bonds” 
within molecules such as nucleoside diphosphate and nucleoside triphosphate (i.e., adenosine 5' 
diphosphate and adenosine 5’ trisphosphate, ADP and ATP, respectively), phosphoenolpyruvate, 
carbamoyl phosphate, 2,3-bisphosphoglycerate, and other phosphates like phosphoarginine or 
phosphocreatine. Among them, ATP is the effective central link—the exchange coin—between 
energy producing and the energy demanding processes that effectively involve formation, 
hydrolysis or transfer of the terminal phosphate group. 
In general, the main energy source for cellular metabolism is glucose, which is catabolized in the 
three subsequent processes: glycolysis, tricarboxylic acid cycle (TCA or Krebs cycle), and finally 
oxidative phosphorylation to produce ATP. In the first process, when glucose is converted into 
pyruvate the amount of ATP produced is low. Subsequently, pyruvate is converted to acetyl 
coenzyme A (acetyl-CoA) which enters the TCA cycle, enabling the production of NADH. Finally, 
NADH is used by the respiratory chain complexes to generate a proton gradient across the inner 
mitochondrial membrane, necessary for the production of large amounts of ATP by mitochondrial 
ATP synthase. In addition, it should be mentioned that acetyl-CoA could be generated also by lipid 
and protein catabolism. 
 
Citric Acid Cycle 
The TCA, also known as the citric acid cycle, was elucidated by Sir Hans Krebs in 1940 when he 
concluded, “the oxidation of a triose equivalent involves one complete citric acid cycle” (13). The 
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“triose” deriving from glycolysis is completely oxidized into three molecules of CO2 during a 
sequence of reactions that allow the reduction of cofactors NAD and flavin adenine nucleotide 
(FAD), providing energy for the respiratory chain in the form of electrons. In 1949 it was 
demonstrated by Kennedy and Lehningher that the entire cycle occurs inside mitochondria (14). 
The starting material for the citric acid cycle is directly provided by the pyruvate coming from 
glycolysis through the activity of the pyruvate dehydrogenase complex. This enzymatic complex, 
composed of multiple copies of the three enzymes pyruvate dehydrogenase (E1), dihydrolipoyl 
transacetylase, (E2) and dihydrolipoyl dehydrogenase (E3), oxidizes pyruvate to acetyl-CoA and 
CO2 in an irreversible reaction in which the carboxyl group is removed from pyruvate as a molecule 
of CO2. This reaction is strictly related to the cycle, even if is not comprised in it. The acetyl group 
introduces two carbons in each turn of the cycle; these carbons will then leave the cycle as CO2. 
The first reaction of the citric acid cycle is the condensation of one Acetyl-CoA and a molecule of 
citrate to generate oxaloacetate and is catalysed by citrate synthase. Citrate is then transformed into 
isocitrate by aconitase through the formation of cis-aconitate. This step is reversible and could lead 
to the formation of both citrate and isocitrate. Only the fast consumption of isocitrate by its 
dehydrogenase can force the reaction to the proper direction. Isocitrate dehydrogenase catalyses the 
first irreversible oxidation leading to the decarboxylation of isocitrate, generating CO2 and 
α-ketoglutarate. The second carbon leaves the cycle in the following step, when the newly 
generated α-ketoglutarate is immediately decarboxylated by the α-ketoglutarate dehydrogenase 
complex in a reaction similar to the pyruvate decarboxylation. In fact, both these complexes share 
high similarities in enzyme amino acid composition and in the organization of the different 
subunits. Energy released from both oxidations is used to generate NADH from NAD that directly 
feeds into the respiratory chain.  
The following step is catalysed by succinyl-Coa synthetase and utilizes the energy derived from the 
CoA removal to phosphorylate GDP (or ADP) to GTP (or ATP). Selectivity for the nucleotide is 
determined by the isozyme involved. It has been well established that at least two isozymes of 
succinyl-CoA synthetase are expressed in animal tissues (15) and the proportion between them 
seems to be tissue specific. 
The succinate generated in the previous step is the 4 carbon compound that is then converted, by 
three sequential reactions, to oxaloacetate to conclude the cycle. The first of these steps is the 
oxidation of succinate to fumarate by succinate dehydrogenase. This enzyme, tightly bound to the 
inner mitochondrial membrane (IMM), catalyses FAD reduction to FADH2 that provides electrons 
for the respiratory chain. Fumarate is then hydrated by fumarate hydratase to L-malate. It is 
particularly interesting that both succinate dehydrogenase and fumarate hydratase are 
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oncosuppressor genes. It has been demonstrated that inactivation of these oncosuppressors leads to 
the accumulation of succinate and fumarate that spread in the cytosol and promote hypoxia-
inducible factor 1α (HIF1α) accumulation by inactivating prolyl hydroxilase enzymes (promoter of 
HIF1α degradation); HIF1α in turn promotes a pseudo-hypoxic condition that favours tumour 
development (16). The last event that completes the citric acid cycle is the oxidation of L-malate to 
oxaloacetate. This reaction is performed by L-malate dehydrogenase, which induces the reduction 
of another molecule of NAD to NADH. The resulting molecule of oxaloacetate is suitable for 
starting another cycle through condensation with an acetyl group. 
During all these processes, only one molecule of ATP (or GTP) is produced, but three molecules of 
NADH and one of FADH2 (plus one molecule of NADH from pyruvate dehydrogenase), which 
provide electrons for respiratory chain, are also generated and subsequently result in the production 
of large amounts of ATP (discussed later). 
 
Fig1. Dynamic remodelling within mitochondrial network. (A) fast confocal imaging of mitochondria stained with 
mtDsRed. (B) Time series of cell portion enlightened in A showing mitochondrial fission, each step is separated by 1sec 
delay 
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Respiratory chain and Oxidative Phosphorylation 
Respiratory chain comprises a series of components (complexes) conducting electron transfer 
across the membrane and involved in oxidative phosphorylation (OXPHOS), a process that occurs 
in aerobic conditions. In eukaryotic cells, electron transport occurs in mitochondria and 
chloroplasts, whereas in bacteria it is carried out across the plasma membrane. As mentioned, the 
electron transfer is considered a part OXPHOS, the process through which ADP is phosphorylated 
into ATP by dint of energy derived from the oxidation of nutrients. 
Four protein complexes and ATP synthase, all bound to the IMM, as well as two shuttles are the 
known players of one of the trickiest mechanisms resolved in biochemistry. The first of these 
complexes is the NADH:ubiquinone oxidoreductase (complex I) which removes electrons from 
NADH (produced in the citric acid cycle) and passes them on to the first shuttle, ubiquinone, a 
liposoluble cofactor located within the phospholipid bilayer of the IMM. Succinate dehydrogenase 
(or complex II) is another entrance site for electrons into the respiratory chain. In this case, 
electrons derived from the oxidation of succinate are passed through FAD to ubiquinone. Once 
ubiquinone is reduced to ubiquinol, it is able to pass electrons to the third complex, 
ubiquinone:cytochrome c oxidoreductase. Here, electrons are moved through several heme groups 
from the liposoluble shuttle ubiquinone to the water soluble shuttle cytochrome c. Cytochrome c is 
a small protein (about 12.5 kDa), located in the intermembrane space (IMS), which can 
accommodate one electron in its heme group. Despite its water solubility, cytochrome c is usually 
bound to the external surface of the IMM due to the interaction with the cardiolipin (17). This 
interaction (crucial in the determination of the cell fate) helps the shuttle to reach its electron 
acceptor, complex IV. Cytochrome c oxidase is the last complex of the electron transport. Electrons 
from cytochrome c are accumulated in copper centres and passed to oxygen through heme groups. 
Oxygen is then reduced to water. This constitutes the bulk of oxygen consumption in all aerobic 
life. 
Electron transport through complexes I, III and IV induces the pumping of protons from the matrix 
to the IMS.  Specifically, for every two electrons coming from one molecule of NADH, four H+ are 
moved by complex I, four by complex III, and two by complex IV. The second respiratory complex 
does not generate any proton movement (18). The respiratory chain in active mitochondria 
generates a large difference in [H+] across the IMM, resulting in the generation of an electrical 
potential (about -180 to -200 mV) and variation in the pH of about 0.75. A constant proton motive 
force drives the ATP synthesis trough the last step of OXPHOS, the ATP synthase. Understanding 
the activity and organization of this enzyme won researchers more than one Nobel Prize. First, Peter 
Mitchell in 1978 received his prize for the formulation of the chemiosmotic theory. Initially he 
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hypothesized how an enzymatic activity could at the same time involve ion transport (proton 
transport through the IMM) and a chemical reaction (ATP phosphorylation). Almost two decades 
later, in 1997, the Nobel Prize was awarded to Paul Boyer and John Walker who elucidated the 
mechanism of action of ATP synthase, here briefly reviewed. ATP synthase could be divided in two 
main components: F0 that allows the channelling of protons, and F1 that catalyses ATP 
phosphorylation. The F0 is embedded in the IMM, while the F1 resides in the mitochondrial matrix 
and is bound to the F0 through a γ subunit (which drives conformational changes) and a b2δ dimer 
(that holds F0 and F1 together). The protons flow from the intermembrane space to the matrix 
through the F0 inducing its rotation; the movement is transmitted from the γ subunit to the F1 
causing conformational rearrangements. The F1 has a trimeric structure consisting of αβ dimers. 
The sequential changes are linked to the binding of substrates, phosphorylation and release of ATP. 
The three available dimers are never in the same conformational state and, what is more, the 
conformational changes in one dimer drive rearrangements in the other (for a more detailed 
explanation refer to (19)). It has been calculated that for the synthesis of one ATP molecule, 4 
protons are required (3 for the ATP synthase rearrangements and 1 for ATP, ADP and Pi transport, 
(20)). Once synthetized, ATP can locate inside mitochondrial matrix or be transported into the IMS 
by the nucleotide exchanger adenine nucleotide translocase (ANT) that passively exchanges ATP 
with ADP. Once in the IMS, ATP can freely pass the OMM through the voltage dependent anion 
channel (VDAC). 
 15 
 
 
Fig2. A schematic representation of principal metabolic reactions occurring within mitochondria. Glycolysis is 
represented in the yellow and blue boxes, the TCA cycle by the green circle, and oxidative phosphorylation in the 
orange box. Reduction of pyruvate to lactate is represented inside the red dotted rectangle. Hypothetical contacts 
between ATP storage vesicles and mitochondria, with preferential ATP transfer, are shown within the red dotted circle. 
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Mitochondria: versatile players between cell proliferation and death 
At the same time, mitochondria are also important checkpoints of the apoptotic process, as they 
may release caspase cofactors (21). Indeed, the apoptotic intrinsic pathway is activated by the 
release of several mitochondrial proteins into the cytosol. The main player in the finely tuned 
apoptotic activation process is undoubtedly cytochrome c. The majority of cytochrome c is tightly 
bound to mitochondrial inner membrane, thanks to its electrostatic interactions with acidic 
phospholipids, but a small fraction probably exists loosely attached to inner mitochondrial 
membrane and available for mobilization. 
This protein is an irreplaceable component of the mitochondrial electron transport chain, shuttling 
electrons from complexes III to IV, and is thus essential to life: the disruption of its only gene is 
embryonic lethal (22). Once released in the cytoplasm, this protein drives the assembly of a 
caspases activating complex together with Apaf-1 (apoptosis–protease activating factor 1) and 
caspase 9, the so-called ‘apoptosome’. Cytochrome c, once in the cytosol, induces the 
rearrangement and heptaoligomerization of Apaf-1: each of these complexes can recruit up to seven 
caspase molecules, leading to their proteolytic self-processing and consequent activation (23). 
Mitochondria contain several other proapoptotic, intermembrane space-resident proteins, such as 
Smac/ DIABLO, HtrA2/Omi, AIF and EndoG. DIABLO (direct inhibitor of apoptosis-binding 
protein with a low isoelectric point) and HtrA2 (high temperature requirement protein A2) both 
have an N-terminal domain that can interact and inhibit IAPs (inhibitor of apoptosis proteins). IAPs, 
such as XIAP, cIAP-1 and cIAP-2, are cytosolic soluble peptides that normally associate and 
stabilize procaspases, thus preventing their activation. Conversely, apoptosis-inducing factor and 
EndoG (endonuclease G) translocate from intermembrane space to the nucleus upon treatment with 
several apoptotic stimuli where they seem to mediate chromatin condensation and DNA 
fragmentation (24). 
In HeLa cells upon ceramide treatment, we observed Ca2+ release from the ER and loading into 
mitochondria. As a consequence, organelle swelling and fragmentation were detected that were 
paralleled by the release of cytochrome c. These changes were prevented by Bcl-2 expression as 
well as experimental conditions that lowered [Ca2+]er (25). Mitochondrial permeability transition 
pore (PTP: a large conductance channel that opens through a conformational change of its still 
debated protein components) opening in ceramide-dependent apoptosis was directly demonstrated 
by Hajnoczky and colleagues (26) who could demonstrate that the lipid mediator facilitates PTP 
opening. In this case, ceramide acts as a ‘mitochondrial sensitizer’ that transforms physiological 
IP3-mediated Ca2+ signals into inducers of apoptosis. 
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The Bcl-2 protein family controls the above-described intrinsic pathway of apoptosis. Proapoptotic 
Bax and Bak proteins exist as inactive monomers in viable cells with Bax localizing in the cytosol, 
loosely attached to membranes, and Bak residing in mitochondrial fraction. Upon apoptosis 
induction, Bax translocate to mitochondria where it homo-oligomerizes and inserts in the outer 
membrane; similarly, also Bak undergoes a conformational change, which induces its 
oligomerization at the outer mitochondrial membrane. Together, these events trigger mitochondrial 
outer membrane permeabilization, the crucial process mediating the release of intermembrane 
space-resident caspase cofactors into the cytoplasm (27). 
Mitochondria also undergo a more ‘macroscopic’ remodelling of their shape during the programed 
cell death. Indeed, after apoptosis induction, mitochondria become largely fragmented, resulting in 
small, rounded and numerous organelles. This process occurs quite early in apoptotic cell death, 
soon after Bax/Bak oligomerization, but before caspase activation. Interestingly, the perturbation of 
the equilibrium between fusion and fission rates seems to correlate with cell death sensitivity. In 
particular, conditions in which mitochondrial fission is inhibited, such as DRP1 (dynamin-like 
protein 1) downregulation or mitofusins overexpression, strongly delay caspase activation and cell 
death induced by numerous stimuli. Similarly, stimulation of organelle fission (by DRP1 
overexpression or Mfn1/2 and OPA1 inhibition) promotes apoptosis by facilitating cytochrome c 
release and apoptosome assembly (28). However, the relationship between mitochondrial 
fusion/fission and apoptosis is complex and mitochondrial fragmentation is not necessarily related 
to apoptosis. Indeed, mitochondrial fission per se does not increase cell death and DRP1 
overexpression has been reported to protect cells from some apoptotic challenges, such those 
dependent on mitochondrial Ca2+ overload (29). 
Another hallmark of apoptosis is the loss of mitochondrial membrane potential, secondary to the 
opening of mPTP triggered by different pathological conditions (e.g., Ca2+ overload, ATP 
depletion, oxidative stress, high inorganic phosphate or fatty acid). The molecular structure of this 
pore is currently highly debated, but the main players in mPTP assembly seem to include the 
adenine nucleotide transporter (ANT) in the inner membrane, the voltage-dependent anion channel 
(VDAC), the peripheral benzodiazepine receptor in the outer membrane and cyclophilin D, a matrix 
protein (30). The availability of chemical mPTP inhibitors such as cyclosporine A and related 
compounds lacking the cytosolic inhibitory effect on calcineurin, as well as the development of 
cyclophilin D knockout mouse will help to clarify the role of mPTP in physiological and 
pathological condition and identify areas of pharmacological intervention in common disorders 
such as ischemia-reperfusion injury, liver diseases, neurodegenerative and muscle disorders (31-
33). 
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Interestingly, some of the proposed components of the mPTP participate in Ca2+ homeostasis. 
Indeed, transient expression of VDAC enhanced the amplitude of the agonist-dependent increases 
in mitochondrial matrix Ca2+ concentration by allowing the fast diffusion of Ca2+ from ER release 
sites to the inner mitochondrial membrane. As to the functional consequences, VDAC 
overexpressing cells are more susceptible to ceramide-induced cell death, thus confirming that 
mitochondrial Ca2+ uptake has a key function in the process of apoptosis (34). ANT 
overexpression instead reduced the amplitude of the [Ca2+ ]m peak following ER Ca2+ release, and 
this effect was partially reversed by treating the cells with cyclosporine A, suggesting the 
involvement of mPTP in ER-mitochondria Ca2+ transfer (35). Moreover, mitochondria are 
quantitatively the most important source of intracellular reactive oxygen species and leak from the 
electron transfer chain is supposed to be the main route (36). Recently, a totally new, unexpected 
pathway has emerged that involves p66Shc in mitochondrial reactive oxygen species production. 
Intriguingly, upon phosphorylation by PKCb and peptidyl–prolyl cis/trans isomerase (Pin1) 
recognition, p66shc translocates to mitochondria (37) where it exerts its own oxidoreductase 
activity (38). As a consequence, p66shc directly oxidizes cytochrome c (thus allowing electron to 
escape mitochondrial electron transport chain) and generates H2O2, leading to mPTP opening and in 
turn cell death. The existence of a protein that ‘steals’ electrons from the mitochondrial electron 
transport chain and produces reactive oxygen species provides direct evidence for the role of 
reactive oxygen species in signal transduction, that may represent the biochemical basis of the free 
radical theory of ageing (39). 
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Fig3. The prolonged Ca2+ uptake by mitochondria during apoptotic stimulation. In upper panel a representative 
kinetic of Ca2+ accumulation within mitochondria during the proapoptotic stimulus C2-ceramide measured with 
aequorin. In the lower panel confocal images of mitochondria stained with mtGFP and exposed to the same stimulation 
 
Mitochondria associated Membranes MAM 
Mitochondrial and ER networks are fundamental for the maintenance of cellular homeostasis and 
for the determination of cell fate under stress conditions (40). Recent structural and functional 
studies revealed the interaction of these networks. These zones of close contact between ER and 
mitochondria, called MAM (41), support the communication between the two organelles involved 
in bioenergetics and cell survival. 
Close appositions between the ER (or sarcoplasmic reticulum, SR) and mitochondria have long 
been known to exist and have been observed by electron microscopy (EM) in fixed samples of 
several cell types. These regions have long been considered to represent the sites of phospholipid 
exchange between the two organelles. Although such close appositions between ER and 
mitochondria may, at least in part, represent fixation artefacts, an EM picture taken from quickly 
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frozen samples, which prevents most artefacts of chemical fixation, reveals that such close 
appositions are not only visible, but are actually more frequent than in traditionally fixed samples.  
Experiments in living cells with the two organelles labelled by GFP (4) and electron micrograph 
images of quickly frozen samples (42) have demonstrated conclusively that such physical 
interactions between the two organelles indeed exist. Recently, it has also been shown by electron 
tomography that ER and mitochondria are adjoined by tethers (43) (10 nm at the smooth ER and 
25 nm at the rough ER) (Fig.4) and that coupling between these two organelles can be weakened (or 
strengthened) by rupture (or enforcement) of this inter-organelle protein linkage (44). Some 
evidence supports the hypothesis that the movement of mitochondria might occur concomitantly 
and in synchrony with that of specific ER regions. The mechanism of this reciprocal organelle-
docking remains unresolved but it has been proposed that it depends on the expression on both 
membranes, of complementary proteins that link the two organelles together, possibly at specific 
sites (45). 
  
Fig4. A schematic representation of the organization of MAM. The model MAM include key players of lipid 
metabolism, Ca2+ signalling elements (receptor of inositol 4,5-trisphosphate (IP3R), voltage dependent anion channel 
(VDAC), chaperones (PACS-2: phosphofurin acidic cluster sorting protein 2, grp75: glucose-regulated protein 75, Sig-
1R: Sigma-1 receptor) and peptidic tethers keeping mitochondria and ER in close contact. (B) Rapresentative volume 
rendering fro HaLa cell stained with er-GFP and mtDsRed. (C) Region selected from image (B) was zoomed and 
rendered with isosurface for mitochondria (Red) and volume for ER (green). Contact sited are shown in white. 
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In particular it has been identify a tethering complex, composed of proteins resident of both ER and 
mitochondria, Mmm1/Mdm10/Mdm12/Mdm34, that was functionally connected to Ca2+ and 
phospholipids exchange between the two organelles (43). 
MAM contain multiple phospholipid- and glycosphingolipid-synthesizing enzymes, including long-
chain fatty acid-CoA ligase type 4 (FACL4) and phosphatidylserine synthase-1 (PSS-1) (Fig.4), and 
support direct transfer of lipids between the ER and mitochondria (46, 47). In addition, MAM also 
exchange Ca2+ ions which regulate processes ranging from ER chaperone-assisted folding of newly 
synthesized proteins to the regulation of mitochondria-localized dehydrogenases involved in ATP-
producing Krebs cycle reactions, and the activation of Ca2+-dependent enzymes that execute cell 
death programs (48).  Recently, several proteins bound to mitochondria or ER have been shown to 
be important for maintaining the spatial relationship between the two organelles (49). 
The interactions between the two organelles seem to be modulated by a family of “mitochondria-
shaping proteins” and by a family of chaperone proteins. In mammals, the best characterized of the 
“mitochondria-shaping proteins” are DRP-1 (9) and Mitofusin 1 and 2, that regulate mitochondria 
fission and fusion (50). 
MAM are also enriched in key chaperones that may play a role in regulating Ca2+ signalling 
between ER and mitochondria.  Moreover they noted that in physiological conditions Sig-1R is 
retained in the MAM. Upon ER stress, redistribution of Sig-1Rs occurs, from MAM to the 
periphery of the ER.  
Interestingly, Sig-1Rs and the 3 isoform of IP3R co-localize and associate with each other at MAM, 
Sig-1Rs form a Ca2+-sensitive chaperone machinery with BiP (immunoglobulin binding protein also 
known as 78-kDa glucose-regulated protein GRP78) and prolong Ca2+ signalling from the ER to 
mitochondria by stabilizing IP3R-3 at MAM. (51).  
In addition, Simmen et al. demonstrated that PACS-2 is a multifunctional sorting protein that 
controls the ER–mitochondria axis and the role of this axis in cellular homeostasis and apoptosis. 
They showed that PACS-2 is required for the intimate association of mitochondria with the ER. 
PACS-2 depletion induces mitochondria fragmentation and uncouples this organelle from the ER, 
raising the possibility that, in addition to mediating MAM formation, PACS-2 might also influence 
ER folding and Ca2+ homeostasis. 
The requirement of PACS-2 for the apposition of rod-like mitochondria to the ER suggests that 
PACS-2 has an essential role in ER-mitochondria communication, and influences the dynamic 
mitochondria fusion/fission events that are coupled with mitochondria homeostasis and inter-
mitochondria communication (52). 
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In addition to mediating the ER-mitochondria axis, PACS-2 was found to have a profound role on 
ER homeostasis. Indeed, both IP3Rs and RyRs possess potential PACS-2-binding sites (53) and 
may be associated with MAM (54). Thus, disruption of PACS-2 may cause mislocalization of 
IP3Rs, resulting in reduced Ca2+ transfer from the ER to mitochondria.  
Finally, in a recent study, it has been demonstrated that the IP3R-mediated mitochondrial Ca2+ 
signalling is regulated by the mitochondrial chaperone grp75 (55). In particular, isoform 1 of 
VDAC is physically linked to the ER Ca2+-release channel IP3R through grp75, highlighting 
chaperone-mediated conformational coupling between the IP3R and the mitochondrial Ca2+ uptake 
machinery (Fig.4). 
These findings together support a new emerging picture whereby chaperone machineries at both ER 
and mitochondrion orchestrate the coordinate regulation of Ca2+ signalling between these two 
organelles. 
 
The concept of Ca2+ as a cellular signal 
In the past two decades, our understanding of how extracellular signals are conveyed to eukaryotic 
cells via an increase in intracellular Ca2+ concentration has widely expanded. It is today common 
knowledge that a variety of extracellular stimuli (ranging from the binding of hormones, 
neurotransmitters, growth factors to phenomena such as cell-cell interactions), through diverse 
mechanisms (e.g. receptors that are themselves ion channels, or have an intrinsic enzymatic activity 
or are coupled to enzymatic effectors via G proteins) induce a rise in cytoplasmic Ca2+ 
concentration ([Ca2+]c) with defined amplitude and kinetics (56); (57). 
In most eukaryotic cells, a large electrochemical gradient for Ca2+ exists across the plasma 
membrane. The transmembrane potential across the membrane is 70 to 90 mV. The interior of the 
cell is the more negative, yet the cytoplasmic concentration of Ca2+ ([Ca2+]c) is less than one-ten 
thousandth of that in the extracellular milieu. There are also intracellular organelles, such as the 
endoplasmic reticulum (ER) and secretory granules, that contain one to ten thousand fold greater 
concentrations of Ca2+ than the cytoplasm. 
Moreover, the technological advancements in probe design and imaging systems, by allowing the 
accurate measurement [Ca2+] at the single cell level, has revealed a marked asynchronicity in cell 
response and a high spatio-temporal complexity of the intracellular Ca2+ signal. We now know that 
the Ca2+ signal can be conveyed as repetitive [Ca2+]c spikes (commonly referred to as Ca2+ 
oscillations) (58) as well as localised [Ca2+]c increases that may either be confined or gradually 
propagate to the rest of the cell (“Ca2+ waves”) (59),(60).  
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An extensive Ca2+-signalling toolkit is used to assemble signalling systems with very different 
spatial and temporal dynamics. Rapid highly localized Ca2+ spikes regulate fast responses, whereas 
slower responses are controlled by repetitive global Ca2+ transients or intracellular Ca2+ waves. The 
Ca2+ has a direct role in controlling the expression patterns of its signalling systems that are 
constantly being remodelled in both health and disease. During the on reaction, stimuli induce both 
the entry of external Ca2+ and the formation of second messengers that release internal Ca2+ that is 
stored within the endoplasmic reticulum or Golgi apparatus. Most of this calcium is bound to 
buffers, whereas a small proportion binds to the effectors that activate various cellular processes. 
During the off reactions, Ca2+ leaves the effectors and buffers and is removed from the cell by 
various exchangers and pumps. The Na+/Ca2+ exchanger (NCX) and the plasma membrane Ca2+-
ATPase (PMCA) extrude Ca2+ to the outside, whereas the sarco/endoplasmic reticulum Ca2+-
ATPase (SERCA) pumps Ca2+ back into the ER.  
Mitochondria also have an active function during the recovery process in that they sequester Ca2+ 
rapidly trough a uniporter, and release more slowly back into the cytosol to be dealt with by the 
SERCA and the PMCA. Cell survival is dependent on Ca2+ homeostasis, whereby the Ca2+ fluxes 
during the off reactions exactly match those during the on reaction. 
 
Aequorin 
In the last decade the study of Ca2+ homeostasis within organelles in living cells has been greatly 
enhanced by the utilisation of a recombinant Ca2+-sensitive photoprotein, aequorin. aequorin is a 
Ca2+ sensitive photoprotein of a coelenterate that, in the past, was widely employed to measure Ca2+ 
concentration in living cells. In fact the purified protein was widely used to monitor cytoplasmic 
[Ca2+] changes in invertebrate muscle cells after microinjection. However, due to the time-
consuming and traumatic procedure of microinjection, the role of aequorin in the study of Ca2+ 
homeostasis remained confined to a limited number of cells (giant cells) susceptible to 
microinjection. Thus in most instances, it was replaced by the fluorescent indicators developed by 
Roger Tsien and co-workers. The cloning of aequorin cDNA (61) and the explosive development of 
molecular biology offered new possibilities in the use of aequorin, as microinjection has been 
replaced by the simpler technique of cDNA transfection. As a polypeptide, aequorin allows the 
endogenous production of the photoprotein in cell systems as diverse as bacteria, yeast, plants and 
mammalian cells. Moreover, it is possible to specifically localise it within the cell by including 
defined targeting signals in the amino acid sequence. Targeted recombinant aequorins represent to 
date the most specific means of monitoring [Ca2+] in subcellular organelles. 
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General properties of aequorin. 
 
aequorin is a 21 KDa protein isolated from jellyfish of the genus Aequorea that emits blue light in 
the presence of calcium. The aequorin originally purified from the jellyfish is a mixture of different 
isoforms called “heterogeneous aequorin” (62). In its active form the photoprotein includes an 
apoprotein and a covalently bound prosthetic group, coelenterazine. As schematically shown in 
Fig.5 when calcium ions bind to the three high affinity E-F hand sites, coelenterazine is oxidized to 
coelenteramide, with a concomitant release of carbon dioxide and emission of light.  
Fig.5: Scheme of the Ca2+ induced photon emission process. 
Fig.6: Relationship between the free Ca2+ concentration and the rate of aequorin photon emission. The fractional 
rate of aequorin consumption is expressed as the ratio between the emission of light at defined [Ca2+] (L) and the 
maximal rate of the light emission at saturating [Ca2+] (L max). 
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Although this reaction is irreversible, in vitro an active aequorin can be obtained by incubating the 
apoprotein with coelenterazine in the presence of oxygen and 2-mercaptoethanol. Reconstitution of 
an active aequorin (expressed recombinantly) can be obtained also in living cells by simple addition 
of coelenterazine to the medium. Coelenterazine is highly hydrophobic and has been shown to 
permeate cell membranes of various cell types, ranging from the slime mold Dictyostelium 
discoideum to mammalian cells and plants (63). 
Different coelenterazine analogues have been synthesized that confer to the reconstituted protein 
specific luminescence properties (64). A few synthetic analogues of coelenterazine are now 
commercially available from Molecular Probes.  
The possibility of using aequorin as a calcium indicator is based on the existence of a well-
characterized relationship between the rate of photon emission and the free Ca2+ concentration. For 
physiological conditions of pH, temperature and ionic strength, this relationship is more than 
quadratic in the range of [Ca2+] 10-5-10-7 M. The presence of 3 Ca2+ binding sites in aequorin is 
responsible for the high degree of cooperativity, and thus for the steep relationship between photon 
emission rate and [Ca2+] (Fig.6). The [Ca2+] can be calculated from the formula L/Lmax where L is 
the rate of photon emission at any instant during the experiment and Lmax is the maximal rate of 
photon emission at saturating [Ca2+]. The rate of aequorin luminescence is independent of [Ca2+] at 
very high (>10-4 M) and very low [Ca2+] (< 10-7 M). However, as described below in more details, it 
is possible to expand the range of [Ca2+] that can be monitored with aequorin. Although aequorin 
luminescence is not influenced either by K+ or Mg2+ (which are the most abundant cations in the 
intracellular environment and thus the most likely source of interference in physiological 
experiments) both ions are competitive inhibitors of Ca2+ activated luminescence. Sr2+ can also 
trigger aequorin photon emission but its affinity is about 100 fold lower than that of Ca2+, while 
lanthanides have high affinity for the photoprotein (e.g. are a potential source of artefacts in 
experiments where they are used to block Ca2+ channels). pH was also shown to affect aequorin 
luminescence but at values below 7. Due to the characteristics described above, experiments with 
aequorin need to be done in well-controlled conditions of pH and ionic concentrations, notably of 
Mg2+.  
 
Recombinant aequorins 
The cloning of the aequorin gene has opened the way to recombinant expression and thus has 
largely expanded the applications of this tool for investigating Ca2+ handling in living cells. In 
particular, recombinant aequorin can be expressed not only in the cytoplasm, but also in specific 
cellular locations by including specific targeting sequencing in the engineered cDNAs.  
 26 
Extensive manipulations of the N-terminal of aequorin have been shown not to alter the 
chemiluminescence properties of the photoprotein and its Ca2+ affinity. On the other hand, even 
marginal alterations of the C-terminal either abolish luminescence altogether or drastically increase 
Ca2+ independent photon emission (65). As demonstrated by Watkins and Campbell, (66) the C-
terminal proline residue of aequorin is essential for the long-term stability of the bound 
coelenterazine. For these reasons, all targeted aequorins synthesized in our laboratory include 
modifications of the photoprotein N-terminal. Three targeting strategies have been adopted:  
1.Inclusion of a minimal targeting signal sequence to the photoprotein cDNA.  
2. Fusion of the cDNA encoding aequorin to that of a resident protein of the compartments of 
interest.  
3. Addition to the aequorin cDNA of sequences that code for polypeptides that bind to endogenous 
proteins.  
 
Chimeric Aequorin cDNAs 
Below I briefly describe the constructs that were present in our laboratory and used in this thesis 
 Fig.7 : Schematic representation of aequorin chimeras.  
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Fig.8. Schematic representation of a custom-built luminometer. Cells loaded with functional aequorin probe are 
incubated in a perfusion chamber, at 37°C, in close proximity to a photon-counting tube. The complete assemblage is 
kept at 4°C, in the dark, to minimize extraneous signals. Acquisition of the data and subsequent calculations to 
transform light emission into [Ca2+] are performed by a dedicated computer algorithm. 
 
 Cytoplasm (cytAEQ) 
An unmodified aequorin cDNA encodes a protein that, in mammalian cells is located in the 
cytoplasm and, given its small size, also diffuses into the nucleus. An alternative construct was also 
available that is located on the outer surface of the ER and of the Golgi apparatus. This construct 
was intended to drive the localization of aequorin to the inner surface of the plasma membrane 
given that it derives from the fusion of the aequorin cDNA with that encoding a truncated 
metabotropic glutamate receptor (mgluR1). The encoded chimeric protein, however, remains 
trapped on the surface of the ER and Golgi apparatus, with the aequorin polypeptide facing the 
cytoplasmic surface of these organelles. The cytoplasmic signal revealed by this chimeric aequorin 
is indistinguishable from that of a cytoplasmic aequorin, but it has the advantage of being 
membrane bound and excluded from the nucleus. 
• Mitochondria (mtAEQ) 
 All mitochondrial proteins, but the 13 encoded by the organellar genome, are synthesized on 
cytoplasmic ribosomes and then imported into the organelle. In most cases, import depends on the 
presence of a cleavable signal at the N-terminus of a precursor protein. This signal (rich in basic and 
hydroxylated residues, and devoid of acidic ones) usually referred to as mitochondrial presequence, 
is removed after import by matrix proteases (67). When added to a heterologous protein, a 
mitochondrial presequence is sufficient to drive its import into mitochondria. MtAEQ was the first 
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targeted aequorin generated in the laboratory, which has been successfully employed to measure the 
[Ca2+] of the mitochondrial matrix of various cell types. This construct includes the targeting 
presequence of subunit VIII of human cytochrome c oxidase fused to the aequorin cDNA (68). 
• Endoplasmic Reticulum (erAEQ) 
The erAEQ includes the leader (L), the VDJ and Ch1 domains of an IgG heavy chain fused at the 
N-terminus of aequorin. Retention in the ER depends on the presence of the Ch1 domain that is 
known to interact with high affinity with the luminal ER protein BiP (69). 
 
Luminescence detection  
The aequorin detection system is derived from that described by Cobbold and Lee (70) and is based 
on the use of a low noise photomultiplier placed in close proximity (2-3 mm) of aequorin 
expressing cells. The cell chamber, which is on the top of a hollow cylinder, is adapted to fit 13-mm 
diameter coverslip. The volume of the perfusing chamber is kept to a minimum (about 200 µl). The 
chamber is sealed on the top with a coverslip, held in place with a thin layer of silicon. Cells are 
continuously perfused via a peristaltic pump with medium thermostated via a water jacket at 37°C. 
The photomultiplier (EMI 9789 with amplifier-discriminator) is kept in a dark box and cooled at 
4°C. During manipulations on the cell chamber, the photomultiplier is protected from light by a 
shutter. During aequorin experiments, the shutter is opened and the chamber with cells is placed in 
close proximity of the photomultiplier. The output of the amplifier-discriminator is captured by an 
EMIC600 photon-counting board in an IBM compatible microcomputer and stored for further 
analysis. 
 
Advantages and disadvantages of aequorin compared to other Ca2+ indicators. 
Today numerous indicators are available to measure [Ca2+]. In this section, I will briefly describe 
some advantages and disadvantages of the photoprotein over the most widely used fluorescent 
indicators, the tetracarboxilate dyes such as fura-2, indo-1, fluo-3 etc.  
 
Advantages: 
1) Selective intracellular distribution. Whereas recombinant expressed wild-type aequorin is 
exclusively cytosolic, adding specific targeting sequences can modify the intracellular fate of the 
photoprotein.  
2) High signal-to-noise ratio. Due to the low luminescence background of cells and the steepness of 
the Ca2+ response curve of aequorin, minor variations in the amplitude of the agonist-induced [Ca2+] 
changes can be easily appreciated with aequorin.  
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3) Low Ca2+ buffering effect. Although the binding of Ca2+ by aequorin may, in principle, affect 
intracellular Ca2+ homeostasis, this undesired effect is less relevant than with fluorescent indicators. 
In fact, thank to the excellent signal to noise ratio, aequorin is loaded at a concentration which is 2-3 
orders of magnitude lower than dyes, i.e. usually from <0.1 µM (for the recombinant expressed 
photoprotein) to ~1 µM (in the case of microinjection of the purified photoprotein for single cell 
studies).  
4) Wide dynamic range. It is clearly evident from Fig.6 that aequorin can accurately measure [Ca2+] 
ranging from 0.5 µM to 10 µM, i.e. reaching concentrations at which most fluorescent indicators 
are saturated. Indeed, thank to these properties and to the low buffering effect, it is possible to 
estimate the large [Ca2+]c rises that occur, for example, in neurons (71). Moreover, by introducing 
point-mutations in the Ca2+-binding sites (72), using surrogate cations, such as Sr2+, and/or modified 
prosthetic groups, the sensitivity of the recombinant photoprotein can be further reduced, and thus 
the [Ca2+] can be monitored also in intracellular compartments endowed with high [Ca2+] (e.g. the 
lumen of the ER).  
5) Possibility of co-expression with proteins of interest. A powerful approach for investigating the 
role, and the properties, of the various molecular components of the Ca2+ signalling apparatus is 
either the overexpression of the heterologous protein, followed by the study of the molecularly 
modified cell. This can be accomplished in two ways, either by generating stably transfected cell 
clones, or by transiently expressing the protein of interest in a cell type. While the former is 
associated with various problems (the clone may substantially differ from the parental line, the 
approach cannot be employed with primary cultures, etc.), in transient transfections a major 
problem is the selective analysis of the transfected sub-population. For this purpose, the single-cell 
imaging of positive cells, identified via a co-transfected reporter (e.g. GFP), is effective, but time-
consuming, as a large number of cells must be analyzed to minimize cell-to-cell variability. 
Conversely, with co-transfected aequorin, as the luminescence signal is contributed only by the 
positive cells, the data will average the behaviour of the whole transfected subpopulation. 
 
Disadvantages: 
1) Overestimation of the average rise in cells (or compartments) with inhomogeneous behaviour. 
The steepness of the Ca2+ -response curve of aequorin while accounting for the excellent signal to 
noise ratio is also the cause of a major pitfall in the use of the photoprotein: a small fraction of the 
photoprotein pool exposed to very high [Ca2+], by undergoing a massive light discharge, 
significantly increases the calibrated mean value. Indeed, by using targeted aequorin to monitor 
subplasmalemmal Ca2+ concentration, we measured a mean resting [Ca2+] of 1-2 µM, which most 
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likely does not reflect the real average [Ca2+]pm value, but, rather, the contribution of microdomains 
in the proximity of flickering Ca2+ channels (73). 
2) Low light emission. In distinction to the fluorescent dyes (where up to 104 photons can be 
emitted by a single molecule, before photobleaching occurs), only 1 photon can be emitted by an 
aequorin molecule. Moreover, the principle of the use of aequorin for Ca2+ measurements is that 
only a small fraction of the total pool (varying, in a typical physiological experiment, from 10-7 to 
10-2) emits its photon every second. This means that, out of the 104-105 molecules/cell of a typical 
aequorin transfection, light emission will vary from nil to 1000 photons at most. The consequences 
are quite obvious. While in all cases an appropriate apparatus must be used (see below), this is not a 
major limitation in population studies, as averaging over 103-104 cells, the light signals vary from 
20-30 photons (at resting [Ca2+]) to >105 photons/sec. Conversely, single cell imaging requires very 
high expression and special apparatuses (73) and is endowed with lower spatial and temporal 
resolution than that obtained with fluorescent indicators.  
3) Loading procedure. As a polypeptide, aequorin needs either to be microinjected (in the case of 
the native protein) or transfected in living cells. The well-established procedure of aequorin 
microinjection is obviously limited to a small number of cell models. In the case of recombinant 
aequorin, transfection is the simplest loading procedure. In this respect it should be remembered 
that i) some cell lines may be quite resistant to transfection (although a wide range of procedures is 
now available, ranging from calcium phosphate to liposomes, electroporation and particle gun); in 
many cases, time is required to find the appropriate transfection protocol and ii) time for protein 
expression must be waited before carrying out the Ca2+ measurements; although we detected 
reasonable aequorin expression also 4 hours after transfection, this can be a problem with primary 
cultures with limited time span. 
In summary, aequorins, and in particular targeted recombinant aequorins, may represent for some 
applications a useful, and sometime superior, tool (compared to fluorescent Ca2+ indicators) to 
investigate Ca2+ signalling in living cells. Quite recently the group of Tsien (74) has introduced the 
Ca2+ indicators named “cameleons”, molecularly engineered proteins capable of coupling the 
advantages of aequorins in terms of selective targeting to the high signal characteristics of 
fluorescent molecules. This technique is presently in its infancy, but its potential in this field is 
enormous.  
 
GREEN FLUORESCENT PROTEIN 
GFP is in nature the legitimate partner of aequorin, produced by the same jellyfish (Aequorea 
victoria) and packed in close association to the photoprotein. GFP acts as a natural fluorophore that 
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absorbs the blue light emitted by the photoprotein and re-emits photons of a longer wavelength. 
This accounts for its name and for the greenish blue colour of the jellyfish luminescence (75-77). In 
research applications, GFP retains its fluorescence properties, and thus can be added to the long list 
of probes of the cell biologist’s toolbox (78). Some of its unique properties account for its explosive 
success. In relatively few years (the first report of GFP expression in heterologous systems dates 
back to 1994) (79) GFP has become a powerful and versatile tool for investigating virtually all 
fields of cell biology, ranging from gene expression to protein sorting, organelle structure, 
measurement of physiological parameters in living cells and so on (80, 81).  
The main reason for the success of GFP is its own nature: the fluorescent moiety is a gene product, 
with no need for cofactors, that is open to molecular engineering, transiently or stably expressed 
upon transfection in virtually any cell types. Moreover, its mutagenesis has allowed the adaptation 
of its fluorescence properties to different experimental needs [for a detailed description see reviews 
(78, 82)]. GFP mutants can be grouped in two major classes: the first are the “optimising” 
mutations, i.e. those that increase light emission by either altering the intrinsic properties of the 
fluorescent protein (83, 84) or increasing its production in mammalian cells (85). The latter are the 
so called “humanised” versions of the cDNA, in which silent mutations are introduced that convert 
some of the codons into forms most common and efficient for translation in mammalian cells. As a 
consequence, with equal amounts of mRNA, more fluorescent protein is produced. This property is 
very useful at low mRNA levels (e.g. for the prompt detection of promoter activity). As to the 
modifications of GFP properties, mutations have been described that alter the stability of the protein 
and/or the quantum efficiency upon illumination with visible light. Native GFP has in fact a 
bimodal excitation peak, larger with UV than with blue light, while all currently employed green 
variants of GFP are best excited with blue light, a change that minimizes cytotoxicity and 
photobleaching. Among these mutations, the most useful appears to be the substitution of Ser65 with 
Thr (S65T) that causes the chromophore to be entirely in the anionic form. When compared to wild-
type GFP the quantum efficiency of this mutant upon excitation with blue light is increased 6-fold, 
the rate of fluorophore formation is 4-fold faster and photobleaching is markedly reduced. The 
second class is represented by GFPs emitting light of a wavelength that can be clearly distinguished 
from the green colour of native GFP. This class includes a few popular mutants commonly referred 
to as blue (Y66H, Y145F), cyan (Y66W) and yellow (T203Y) GFPs. 
The search, by mutagenesis, of a truly “red” GFP mutant has been extensive, but unsuccessful. 
Recently, however, a red companion of GFP, RFP, has been isolated from a coral, and is currently 
utilized in numerous labs. Finally, with the notable exception of the blue mutant, all GFPs are 
strongly resistant to photobleaching. This permits the prolonged visualizations of these proteins 
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under the laser illumination of confocal microscopes. For this reason, GFP has often replaced 
already available probes in a variety of applications. 
Another green fluorescent protein, found in the sea pansy Renilla, has been biochemically 
characterized (86) while the cDNA has not been isolated yet. Although the chromophore of Renilla 
is similar to that of Aequorea, some of their biochemical properties differ. Renilla GFP has a much 
higher extinction coefficient, is an obligate dimer and is more resistant to pH-induced 
conformational changes. This could make it useful for specific cell physiology studies.  
Nowadays the most frequent application of the GFPs is that of a tag. In frame fusion of the GFP 
cDNA to the cDNA coding for a protein of interest makes possible the study of the function(s) and 
of the fate of the resulting chimera in living cells. Moreover, chimeras with different spectral 
properties can be employed for visualising simultaneously two proteins of interest (e.g. two 
isoforms of a signalling molecule) or to investigate the morphology and spatial relationship between 
two intracellular compartments. 
GFPs can also be used as a tool for analysing transfection efficiency. In 1994 Chalfie and co-
workers (79) demonstrated the possibility of using GFPs to monitor gene expression in prokaryotic 
(Escherichia coli) and eukaryotic (Caernorhabiditis elegans) living cells. However, some of GFP 
properties (long life-time, time required for fluorophore formation, background fluorescence) are 
not ideally suited for the analysis of promoter activity. In fact Rutter and co-workers (87) imaged 
gene transcription at the single cell level using both GFP and luciferase and showed that the latter 
appears preferable, given that GFP analysis is hampered by the lack of linearity between protein 
concentration and fluorescence intensity and by the interference of cellular autofluorescence.  
GFPs can also be used as sensors for physiological parameters. This approach stems from an 
interesting phenomenon, called fluorescence resonance energy transfer (FRET), occurring between 
two GFPs with different colours. FRET may occur only if the fluorescence emission spectrum of 
the “donor” GFP overlaps with the excitation spectrum of the “acceptor” GFP and if the two 
fluorophores are located within few nanometers in a favourable orientation. Any alterations of these 
parameters can drastically alter the efficiency of FRET. Indeed, the rate of energy transfer is 
proportional to the sixth power of the distance E=[1+(R\R0)6]-1 and thus becomes negligible when 
the two fluorophores are >5-6 nm apart. The earliest use of FRET between GFP mutants was 
reported by Heim and Tsien (88), who linked two fluorophores via a sequence of 25 aminoacid 
including a trypsin cleavage site. After addition of trypsin, the short peptide was cleaved and FRET 
drastically reduced. Many other similar studies have later yielded consistent results (see for example 
(89-91)). 
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FRET was also used by different labs to monitor intracellular Ca2+ changes. Romoser and co-
workers (92) fused BFP and GFP via a linker that included a calmodulin binding site derived from 
smooth muscle myosin light chain kinase.  Addition of Ca2+-calmodulin to this construct disrupted 
FRET probably influencing the correct orientation of the fluorophores. Miyawaki et al. (92) 
developed a chimera called Cameleons, in which appropriate GFP variants were linked by a peptide 
including the N-terminal part of calmodulin and the M13 peptide that associates to calmodulin in a 
Ca2+ dependent manner. Moreover, by targeting this chimera to the ER the authors were able to 
measure the luminal [Ca2+] of this organelle. Finally, FRET between GFP mutants can be employed 
for monitoring protein-protein interactions, such as, for example, Bcl2-Bax (91) and epidermal 
growth factor receptor-Grb2.  
A new biophysical approach, known as bioluminescence resonance energy transfer (BRET), has 
recently been developed. BRET is a phenomenon resulting from radiation-less energy transfer 
between luminescent donor (i.e. with no need of external illumination) and fluorescent acceptor 
proteins. Using this approach and taking advantage of emission spectral overlap between the 
bioluminescent Renilla luciferase and YFP, Xu and colleagues (93) demonstrated 
homodimerization of the cyanobacteria clock protein KaiB in Escherichia coli.  Among the same 
lines, Angers et al. (94) used BRET to reveal dimerization of β2-adrenergic receptors in HEK-293 
living cells.  
 
 
Experimental set-up: collecting and analysing the GFP images. 
 
The fluorophore of GFP is formed by the cyclization of three amino-acid residues of the primary 
sequence. This process directly follows, with few constraints (a relatively brief time lag), the 
synthesis of the protein, and thus GFP proved brightly fluorescent when expressed in a wide variety 
of cell types (mammalian cells, plants, fungi, bacteria, etc.) and intracellular locations (cytoplasm 
and virtually every organelle). Thus, also in our experiments the various GFP chimeras are 
transfected with the appropriate procedure (calcium phosphate, liposomes or particle gun, 
depending on the cell type), and directly visualised in living cells after allowing sufficient time for 
expression and chromophore formation (usually 24-36 hours). For this purpose, the coverslip with 
the transfected cells is fitted at the base of a thermostated chamber, which is placed on the 
microscope stage. 
The microscope set up is presented in figure 8. In brief, a traditional wide-field, epifluorescence 
microscope is equipped with filter-wheels located both in  
 34 
 
Fig.9. A digital imaging system, built on an epifluorescence microscope, is equipped with filter-wheels placed on the 
excitation and emission light paths, a piezoelectric motor and a CCD camera. The system is operated by software that 
also permits to analyse and computationally deblur the images. 
 
The incoming and in the out-coming light paths (thus allowing to rapidly alternate excitation and/or 
emission wavelength) and a piezoelectric transducer (or motor drive) for rapid focussing in the z 
plane. The fluorescence image is collected by a back-illuminated and cooled (-40°C), charge 
coupled device (CCD) camera having high quantum efficiency (>70% at 500nm) and low noise 
(<10e- RMS at 1MHz) characteristics, and the image is stored as a digital file using the 
Metamorph/Metafluor program (Universal Imaging). This allows the direct monitoring of 
fluorescence intensity, important for some applications (e.g. the monitoring of FRET, or the pH 
measurements using the pH-sensitive GFP mutants, a topic that for reasons of brevity will not be 
discussed in this thesis).  
A high-resolution, 3-D reconstruction of the distribution of a GFP chimera can be obtained with the 
technique of digital image restoration, also called deconvolution or deblurring. (95). 
A high-speed version of this microscopy has been developed (4) that can acquire an entire through-
focus image series of a GFP labelled cell in less than 1 second.  This microscope system can be 
used to follow spatial and temporal intracellular dynamics (e.g. motor-protein based transport, 
signal transduction) too rapid for conventional fluorescence microscopy (4); (96).  Conversely, if 
only the time course rather than the 3-D distribution of a fast process (e.g. Ca2+ signalling) needs to 
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be assessed, single fluorescent images of the microscope field of interest can be acquired every 10-
20 ms with no further image processing (97). 
Finally, the filter-wheels allow the alternate imaging of two different fluorophores at different 
excitation and emission wavelengths, and thus the simultaneous visualisation of two different 
proteins of interest in the same cell, or the measurement of donor and acceptor fluorescence in 
FRET applications. When compared to laser scanning confocal microscopy, digital imaging is 
characterised by higher flexibility in the selection of excitation wavelengths, lower illumination 
intensity (thus reducing photobleaching and photodamage) and lower cost. Conversely, its 
disadvantages are the need for time-consuming off-line image processing and the unsuitability for 
the analysis of thick specimen (e. g. tissue slices). 
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p53 interaction with the Sarco/Endoplasmic Reticulum 
Ca2+ ATPase sensitizes mitochondria to apoptosis 
 
Introduction. 
p53 is a master regulator of cell fate 
 
In 1979 six different research groups, independently, reported the discovery of a 53KDa protein, 
present in both human and murine cells, five of this shows how the protein was able to bound the T 
large antigen from SV40, while the sixth that the protein was present in several murine tumour cell 
types (98), (99), (100), (101),(102). 
Initially believed as an oncogene, because of its correlation to the SV40 antigen, in 1989, the TP53 
gene was found mutant in tumour cells compared to the one of neighbouring sane tissues. Definitely 
TP53 was labelled as an oncosuppressor gene, and the p53 used to that date to show its oncogenetic 
activity was effectively a mutant (103) 
Later TP53 has been found as one of the most mutant genes in human tumours and, to date, more 
then 25000 mutations have been reported, most of that as missense mutations. These natural 
occurring mutations has been reported also to be often dominant negative or gain of function for 
oncogenic activities. 
Mutations in p53 alleles are found in more then 50% of human tumours, most of it are concentrated 
within the DBD, in just a few position knowed as Hot Spot. These mutations are able to impair 
proper p53 transcription regulation, but recently several other roles has been proposed (see later). 
The p53 protein is composed of at least 4 domains: 
-­‐ N-terminal trans-activational domain, 
-­‐ A proline-rich domain, for protein interactions (such as for Mdm2), 
-­‐ A DNA binding domain (DBD), 
-­‐ An oligomerization domain (OD), principal target for post-transactional 
modifications such as phosphorylation, acetylation, methylation, ubiquitinilation, 
sumoilation, neddylation, which can influence protein stability or its interactions. 
-­‐  
The presence of a DBD and a trans-activational domain make p53 a transcription factor involved in 
processes like cell cycle block, control of proliferation, apoptosis induction and others all equally 
important in tumour suppression. 
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Fig.10. representation of domains of p53. Domains are represented in different colours; yellow labels indicate 
phosphorylation sites while black bars on upper panel indicate Hot Spot mutation found in human tumours. 
 
In normal conditions p53 is present at very low levels, due to its interaction with the E3-ubiquitin 
ligase Mdm2. This interaction allows constant ubiquitinilation of p53 and its consequent 
degradation via proteasome. During several stress conditions different proteins can phosphorylate 
the binding site for Mdm2 on p53 proline-rich domain inhibiting p53 degradation, allowing a rapid 
accumulation of the protein and engage of its activities (104) 
This peculiarity of p53 response to stress, bid researchers to usually not describe p53 activation 
event (in order of lacking an enzymatically activity), but of p53 stabilization.  
P53 stabilization is induced by a plethora of stimuli, not only of genotoxic nature, but also: 
-­‐ telomeres erosion, 
-­‐ serum starvation, 
-­‐ hypoxic damage, 
-­‐ ribosomal stress, 
-­‐ oncogene activation. 
 
With the ultimate fate to induce cell cycle arrest or apoptosis, but also favouring DNA repair and 
genomic stability, senescence, survival, regulation of metabolism (specially inhibition of glycolysis 
and promotion of respiration), regulation of autophagy, oxidative stress regulation, cell motility and 
cell differentiation. 
 
 Fig.11 the many routes of p53. Blue boxes indicates the activating signals induced in different stress conditions, while 
pink boxes display several induced answers by p53 accumulation. Figure source (105) 
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All these aspects evidence p53 as an overall regulator of cell fate and tissutal homeostasis, 
requiring, within the cell, the presence of a huge amount of regulators of p53 that could act directly 
(i.e. Mdm2), but specially by post-translational regulation and subcellular localization. 
Ability of p53 to regulate gene expression is in turn fundamental to orchestrate all the response 
describe above and to date hundreds of genes has been found directly regulated p53 because of the 
presence of one or more of its consensus sequence i.e. 
p53AIP1, Apaf-1, BAX, Caspase-1 and Caspase 6, cathepsin D, DINP1, DR4, DR5, Fas, IGF-BP3, 
NOXA, p85, PERP, PIDD, PIG3, PTEN, PUMA, Scotin, p21, E124/PIG8. 
Signals stabilizings p53 are not acting all through the same participants or mechanism, i.e. ARF 
protein that bound and inhibits Mdm2 is activated by oncogenes, but is not involved during DNA 
damage stress (106). Similarly the ribosomal protein L11allow p53 stabilization after ribosomal 
stress (107). 
Interestingly the genotoxic activation pathway (induced by radiotherapy and many chemioterapic 
agents) recently has been suggested as the most primitive, but not as the most relevant in order of 
tumour suppression (108), while the most efficient from this point of view appears to be exactly the 
once activated by oncogene activated and mediated by ARF (109). 
P53 stabilization has been recently linked to metabolism, even during non-genotoxic conditions. 
During glucose deprivation p53 activate the AMP kinase (AMPK) that in turn allow cell survival 
(110) moreover Matoba and co-workers in 2006 shown how p53 (111) in basal condition favour the 
expression and assembly of Respiratory Complex IV favouring cell respiration. Loss of p53 in turn 
would favour cell growth and tumour formation even in presence of low nutrient conditions and 
appearance of Warburg effect. 
Moreover p53 has been implicated also in metabolism of reactive oxygen specie as both antioxidant 
and pro-oxidant. Link between p53 and ROS start with observation that p53 could induce genes 
able to promote ROS production (112) as PIG3 and Proline Oxidase (113) as well as it is able to 
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inhibit expression of antioxidant genes (114). This would increase sensitivity to p53 dependent 
apoptosis and, through DNA damage, to induce a feedback loop for p53 activation. 
Nonetheless p53 is also able to induce genes like sestrines (115), glutathione peroxidase (116), 
aldehyde dehydrogenase (117), allowing reduction of levels of ROS. 
 
The mitochondrial route of p53. 
In presence of apoptotic stimulations a distinct fraction of p53 has been shown to translocate to 
mitochondria, where it does interact with pro and anti-apoptotic members of Bcl-2 family in order 
to activate the first and inhibit the latter. This event, occurring even previously of p53 translocation 
to the nucleus would induce a mitochondrial permeability state that induce Cyt C release and 
apoptosis initiation. 
First evidence of p53 translocation to mitochondria arrive from Marchenko et al (118) that show 
how, after its stabilization, a fraction of the protein translocate to mitochondria, preceding 
perturbations of ∆Ψm , Cyt C release and caspase activation. 
At this site p53 interact with Bcl-2 and Bcl-XL, neutralizing their inhibitor activity on the 
proapototic members and Bax and Bak (119) allowing MOMP, moreover, by interaction with Bcl-
Xl, it also able to allow activation of tBid or Bad (120). Apparently this interaction occurs only in 
the central domain of p53, through an electrostatically interaction mediated by positive charges on 
p53 DBD and negative acidic charges of lower domain of Bcl-2/Xl (121). Similarly, trough it’s 
DBD, p53 interacts with Bak, removing the negative regulation mediated by Mcl-1 (122). 
Nonetheless affinity for Bcl-2/Xl is apparently 10 times higher compared to binding with Bak/Bax 
that displays a lower acidic surface neither a BH4 domain, suggesting that p53 preferentially binds 
to Bcl-2/Xl.  
A different explanation for non-nuclear p53 has been proposed involving PUMA. In physiological 
condition cytolasmic p53 would be sequestered in an inhibitory complex with Bcl-Xl. In response 
to stress p53 would translocate to the nucleus where promote transcription of its target PUMA. 
PUMA, in turn, disrupt this complex by binding Bcl-Xl and allowing p53 to activate Bak monomer 
within cytosol (123, 124). 
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Mitochondrial translocation to p53 has been shown to be PUMA and Bax indipendent and would 
allow not only Bak/Bax oligomerization on the OMM, but involved also VDAC, inducing a 
complex formation with cyclophillin D. 
                      
Fig.12 The Bcl-2 model for mitochondrial p53. In normal condition on OMM Bcl-2/XL and Mcl-1 maintain Bax and 
Bak inhibited, p53 by removal of Bcl-2/Xl/Mcl-1 allow the generation of a permeability transition state. Figure source 
(125). 
 
Studies on negative dominant heterozyogusity for p53 with naturally occurring mutants shows how 
the gene transcription is impaired in this condition, while the mitochondrial route appear completely 
normal (126). Should be noticed that, while nuclear p53 act as a tetramer (or dimer of dimers), the 
mitochondrial path appear exerted by monomeric p53, explaining why this route appear not affected 
by tumour derived missense mutants. This phenomen has been explained as a security mechanism 
versus dominant negative mutation. 
Recently also has been show how p53 interact with Mdm4, allowing translocation to mitochondria 
and binding to Bcl-2 (127). Moreover, while interaction between p53 and Bcl-2 occurs even in 
physiological conditions, interaction between Mdm4 and Bcl-2 is dependent by apoptotic 
stimulation. 
This evidences counteract the idea that Mdm4 would be a negative regulator of p53, while propose 
a more fine regulation of p53 levels during transition between physiological state and stressed 
conditions (128, 129). 
Despite these interesting evidences collected about physiology of p53 still is not clear neither which 
are all the cytoplasmic functions of p53 nor which are he pathways allowing p53 to choose its path 
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and specially P53 do not show any translocation sequence (at least within the plethora of the 
knowed once).  
The most relevant post-translational modification linked to this route for p53 is a 
monoubiquitinilation actually (130). Monoubiquitinilation are known as regulatory events linked to 
protein compartmentalization (131, 132), despite the role for ubiquitin in proteasomal degradation, 
where at least 4 copy of the protein has to be linked to the target to induce is removal (133). P53 
monoubiquitinilation is apparently driven by Mdm2 (as the poliubiquitinilation that mediate its 
degradation), but still is not clear what determine the “stop” after the first labelling step. Once to 
mitochondria p53 is rapidly deubiquitinilated by HAUSP, impeding a further ubiquitinilation and 
allowing engagement of apoptosis initiation.  
The mitochondrial p53 induction of apoptosis has been addressed to radiotoxicity in organs like 
thymus and spleen where appear to translocate faster compared to the nuclear translocation. 
Nonetheless this pathway has been also linked to cerebral ischemia and reperfusion damage in 
kidney (134), to such a big extent that inhibiting this mitochondrial route, with a drug called 
pifithrin can allow tissue survival reducing the toxicity due to chiemioterapy (135) 
 
Oncosuppressors as regulators of apoptotic Ca2+ transfer 
Important evidence pointing to a key role of Ca2+ in apoptotic cell death comes from the 
demonstration that oncogenes that protect from cell death perturb intracellular Ca2+ homeostasis. A 
critical link between Ca2+ and apoptosis was established while studying the oncoprotein B cell 
lymphomas 2 (Bcl-2) and its mechanism of action. Bcl-2 is a central regulator of apoptosis, able to 
block or delay apoptosis in different cell types, from hematopoietic to neural (136). The immediate 
interest generated around this protein’s functions led to the discovery of several other proteins 
displaying sequence homology. These are also active in the control of apoptosis and have given rise 
to a whole family of Bcl-2 proteins. 
To date, this family comprises at least thirteen members that can be easily classified, regarding their 
control of apoptosis, as proapoptotic and antiapoptotic (137). The antiapoptotic members conserve 
the higher sequence homology with Bcl-2 and especially within four highly conserved Bcl-2 
Homology domains (BH1-4), like the Bcl-2-related gene A1, BCL-XL, BCL-w, and MCL-1.  
Our group demonstrated how Bcl-2 over-expression was able to reduce the steady state of Ca2+ 
levels within the ER, with resulting reduced Ca2+ transfer to mitochondria during apoptotic 
stimulation and reduced triggering of mitochondrial fragmentation and apoptosis initiation (138, 
139). Other groups have reported similar data, confirming how Bcl-2 could mediate an augmented 
leak from the compartment without affecting activity of ER Ca2+ ATPase (140, 141). Our group 
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also addressed the hypothesis that its putative pore forming activity could mediate regulation of ER 
Ca2+ release, see Fig.13B (142).  Some controversy still remains, however, regarding the 
mechanism through which Bcl-2 reduces the Ca2+ transfer from ER to mitochondria. Bassik et al. 
showed how Bcl-2 alters the phosphorylation of IP3R, promoting its basal leaking (143). A few 
years later, the group of Distelhorst proposed the direct interaction between the BH4 domain of Bcl-
2 and the IP3R, reducing its opening probability and conferring resistance to apoptosis during 
prolonged exposure to the TCR (144). These data was recently confirmed in glioma cell lines. In 
this elegant work, it was shown how the interaction between Bcl-2 and IP3R is able not only to 
inhibit apoptosis, but also to inhibit its propagation through several cells in a Ca2+- and 
IP3-dependent manner (145). 
Observation obtained during part of my phD, indicates as also the PML protein, encoded by a tumor 
suppressor gene implicated in the pathogenesis of leukemia and cancer, plays a critical role in the 
Ca2+ cross talk between ER and mitochondria during apoptotic stimulation. Within the cell PML 
isoforms display both nuclear and cytosolic distribution. At the nucleus PML epitomizes a 
multiprotein nuclear structure, the PML-nuclear bodies (PML-NBs), which depends on PML for its 
formation and function (146, 147) Interestingly, in the cytosol PML is now found to localize at the 
ER and the MAMs (146). MAMs are the specialized domains selectively enriched of mitochondrial 
Ca2+ signaling elements, where Ca2+ transfer between ER and mitochondria takes place. In 
particular, on the ER side MAMs are enriched in IP3R. Pml-/- mice and cells are protected from 
apoptosis triggered by a number of stimuli such as Fas ligand, tumor necrosis factor α and type I 
and II interferons. These effects depend in part on the PML modulation of nuclear transcriptional 
pro-apoptotic pathways (148). However, PML regulates apoptosis also induced by Ca2+ dependent 
stimuli in a transcription-independent way through its ER/MAMs localization. Indeed, in these hot 
signaling sites, PML is shown to regulate the phosphorylation of IP3R by controlling the activity of 
Akt through the recruitment of the PP2A phosphatase at the ER/MAMs. Was in fact demonstrated 
from my group how Akt is able to modulate Ca2+ release from IP3R mediating is antiapoptotic 
effect(149). In so doing, PML is able to regulate Ca2+ mobilization into the mitochondrion, which 
then triggers the cell death program. Conversely, in the absence of PML, PP2A does not accumulate 
in the complexes with IP3R and Akt, and this results in an accumulation of activated Akt (phospho-
Akt).  
These observation are just opening a completely new perspective in which, not only contact sites 
between mitochondria and ER act as a preferential gateway for signals transmission, but where 
components of cytoplasmic and nuclear routes acts to modulate sensitivity to apoptosis, as by 
manipulating a rheostat represented by calcium transmission (fig. 12). 
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Fig.13. different regulation of apoptotic Ca2+ transmission by oncosuppressors. (Ai) kinetics of Ca2+ release from 
ER in MEF PML+/+ and -/- and in HeLa controls compared to HeLa overexpressing Bcl-2 (Bi). The first show reduced 
calcium release, while the latter cause steady state levels PML localize to MAM together with AKT and IP3R3 (Aii), its 
interaction with these components cause alteration of phosphorylation state in IP3R3 mediated by AKT (Aiii). 
Reintroduction of PML localized to ER cause recovery of calcium released during agonist or apoptotic stimulation in 
PML KO. The reduced calcium loaded in Bcl-2 overexpressing HeLa cause mitochondrial protection during stimulation 
with the apoptotic inducer C2-Ceramide (Bii and iii). (C) Schematic rappresentation of the role of oncosuppressors 
PML and Bcl-2 at MAM sites. Adapted from (150) 
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Results  
 
p53 localizes to ER and MAM during stressing condition 
We recently demonstrated the unexpected localization of the promyelocytic leukemia protein 
(PML) at the Endoplasmic Reticulum (ER) and at the Mitochondria-Associated Membranes 
(MAMs) (146), a specialized domains of close contacts between ER and mitochondria, involved in 
maintaining a dynamic cross-talk between the two organelles (151). PML is a tumor suppressor that 
physically interacts and synergizes with p53 in apoptosis induction (152). On the other hand, ER-
mitochondrial cross-talk is fundamental for up-regulating mitochondrial metabolism in stimulated 
cells (153) and plays a key role also in decoding Ca2+-mediated apoptotic signals (44, 51, 154, 155). 
Down-regulation of ER-mitochondrial Ca2+ transfer caused by Bcl-2 over-expression or PML 
impairment is important for the anti-apoptotic effect of these proteins (156).  
On the light of these observations, we verified the intracellular localization of p53 by subcellular 
fractionation, both in primary mouse embryonic fibroblasts (MEFs) and in the human colon cancer 
HCT-116 p53+/+ cell line (157). Similarly to PML, p53 is localized in the nucleus, in the cytosol 
and, interestingly, both in the ER and in the MAMs, but not in the “pure” mitochondrial fraction 
(Fig.14, A and B).  
Since it was previously shown that in the absence of p53 MEF cells were resistant to apoptosis 
induced by thapsigargin (TG) (158) and being p53 localized at ER/MAMs compartments, we 
investigated whether p53 could be a fundamental component of the ER stress-induced apoptotic 
pathway. To address this question we investigated its role in the ER stress induced by H2O2 and 
menadione (MEN), two oxidizing agents that induce ER Ca2+ release. 16 h after applying the stress 
inducers, the percentage of apoptotic cells, determined by flow cytometry analysis, was shown to be 
markedly lower in p53-/- MEFs as compared to wt cells (Fig.14C). The importance of p53 at 
ER/MAMs was further strengthened by the observation of an increase in p53 levels in these regions 
after pharmacological treatment by the potent p53 inducer, adriamycin (Fig.14, D and E).  
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Fig.14 p53 localization at ER and MAM regions is fundamental for its apoptotic activity. Detection of p53 by 
immunoblotting in p53
+/+
 MEFs (A) and HCT-116 p53
+/+
 (B) fractionations. IP3R, Laminin, tubulin and voltage 
dependent anion channel (VDAC) are used as markers. H: homogenate; Mc: crude mitochondria; Mp: pure 
mitochondria; ER: Endoplasmic Reticulum; MAMs: mitochondria associated membranes; C: cytosol; N: nucleus. (C) 
Apoptosis induced by 1 mM H2O2 or 15 µM menadione (MEN) in p53
+/+
 or p53
-/-
 MEFs treated for 16 h. Mean of six 
independent experiments. (D) Accumulation of p53 at ER and MAMs regions after Adriamycin induction in HCT-116 
p53
+/+
 cells. (E) Co-localization of p53 (green) and FACL (long-chain fatty acid-CoA ligase type 4, used as MAM 
marker, red) in p53
+/+
 MEFs in control condition (CTR) and after Adriamycin induction (ADRIA), analyzed by 
immunofluorescence.  
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Calcium homeostasis alterations induced by p53 
The key process connecting apoptosis to ER-mitochondria interaction is an alteration in Ca2+ 
homeostatic mechanisms (159) that results in massive and/or a prolonged mitochondrial Ca2+ 
overload (160). We thus examined the effect on Ca2+ homeostasis of p53 down-regulation and 
induction, respectively. Using recombinant aequorin probes (161), [Ca2+] was measured selectively 
in the cytosol and in organelles acting as source (ER) or target (mitochondria) of cellular Ca2+ 
signals. A striking difference was evident in [Ca2+]er steady state levels (Fig.15A). After p53 
induction by adriamycin, the degree of ER filling was higher, whereas the loss of p53 caused a 
reduction of ER Ca2+ content compared to wt. Conversely, the kinetics of Ca2+ release from ER 
were comparable in all conditions thus suggesting a selective impairment in the Ca2+-import 
mechanisms from the cytosol to the lumen of ER (Fig.15A) (p53+/+: [Ca2+]ER peak 360 ± 21 µM; 
p53-/-: [Ca2+]ER peak 282 ± 32.4 µM; p53+/++ ADRIA: [Ca2+]ER peak 431 ± 28 µM. n=15 from five 
independent experiments and p<0.01). 
In agreement with the [Ca2+]er data, the [Ca2+] increases evoked by stimulation with ATP in the 
mitochondria and in the cytosol were significantly larger after adriamycin treatment and smaller in 
p53-/- than in wt MEFs (Fig.15, B and C) (p53+/+: [Ca2+]m peak 80 ± 16 µM; [Ca2+]c peak 2.5 ± 0.18 
µM. p53-/-: [Ca2+]m peak 43 ± 9.3 µM; [Ca2+]c peak 1.85 ± 0.31 µM. p53+/++ ADRIA: [Ca2+]m peak 
105 ± 14 µM; [Ca2+]c peak 2.9 ± 0.22 µM. n=15 from five independent experiments and p<0.01). 
Similarly, increased Ca2+ traffic from ER to mitochondria was observed both in HeLa cells over-
expressing a p53 wt construct (130) (Fig.16 A, B, C) and in HCT-116 p53+/+ upon Adriamycin 
treatment. (Fig.16D) (HeLa control: [Ca2+]ER peak 228 ± 35 µM; [Ca2+]m peak 42 ± 21 µM; [Ca2+]c 
peak 3.1 ± 0.2 µM. HeLa expressing p53 wt: [Ca2+]ER peak 355 ± 29 µM; [Ca2+]m peak 53 ± 11 µM; 
[Ca2+]c peak 3.7 ± 0.25 µM. n=10 from five independent experiments and p<0.01. HCT-116 p53+/+: 
control peak 1.36 ± 0.5 µM, ADRIA peak 1.7 ± 0.6 µM). 
On the contrary, Adriamycin treatment in MDA-MD 468 breast cancer cells, which are hemizygous 
for p53 mutation, had no effects on Ca2+ homeostasis (Fig.16E) (MDA-MD 468: control peak 6.53 
± 1.3 µM, ADRIA peak 6.47 ± 1.2 µM) as well as in p53-/- MEFs and HCT p53-/- (data not shown). 
To assess if the observed ER Ca2+ overload is a pro-apoptotic condition, we analyzed mitochondrial 
morphology after apoptotic stress induction. Mitochondria of wt MEFs were labelled with targeted 
GFP and mitochondrial volume was evaluated by confocal microscopy. Treatment with H2O2 for 3 
hours caused a strong reduction of the average mitochondrial volume, as expected, upon network 
breakage (Fig.15D). Induction of p53 alone did not significantly affect mitochondrial volume but 
Adriamycin treatment followed by H2O2 exposure induced a greater reduction in mitochondrial 
volume compared to H2O2 alone. As for the volume, Adriamycin alone did not alter the 
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mitochondrial morphology while the combination of Adriamycin and H2O2 caused a strong increase 
of fragmentation (Fig.15D). 
The same experiments were performed in MEF p53 KO to exclude any non-specific effect of 
Adriamycin on mitochondria. As expected H2O2 exposure caused a low reduction on mitochondrial 
volume and increase in fragmentation, but this effect was not significantly influenced by 
Adriamycin pre-treatment (Fig.15D). 
As mentioned above, there is a general literature agreement linking Ca2+ transfer from the ER to 
mitochondria and the effect of apoptotic stimuli. We thus investigated whether the absence or the 
induction of p53 could alter the increases in [Ca2+]m after apoptotic stimuli.  We observed that the 
reduction mediated by the oxidative apoptotic stimuli H2O2 of agonist-dependent mitochondrial 
Ca2+ response, was proportional to p53 expression (Fig.15E). Similarly, the increases in [Ca2+]m, 
evoked by H2O2, triggering a progressive release of Ca2+ from the ER and an activation of the 
capacitative Ca2+ influx (139), were higher after adriamycin p53 induction compared to wt and null 
conditions (Fig.15F). As consequence, the activation and accumulation of p53 to ER/MAMs 
compartments render cells more prone to die after apoptotic stress (Figs. 15, G-H). 
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Fig.15 Alterations of Ca
2+
 homeostasis after p53 induction is Human Tumour cell lines (A-C) Measurements of 
[Ca
2+
] using aequorin upon agonist (100 mM ATP) stimulation in ER (A), mitochondria (B) and cytosol (C). (D) 
Isosurface rendering of p53
+/+ 
and p53
-/- 
MEFs expressing mtGFP in basal conditions, after ADRIA and/or H2O2 
exposure. (E) Mitochondrial Ca
2+
 response ATP dependent in p53
+/+ 
(F) Analysis of [Ca
2+
]m during oxidative stress 
upon H2O2 stimulation (2 mM).  
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Fig 16 Analysis of Ca2+ homeostasis in ER (A), mitochondria (B) and cytosol (C) in HeLa cells in control 
condition and after expression of the p53 wt construct. Measurements were obtained with aequorin targeted 
chimeras after agonist stimulation (100 mM Histamine). Mitochondrial [Ca2+] after ATP stimulation measured in HCT-
116 p53+/+ (D) and MDA-MD 468 (E) cells in control condition and after ADRIA treatment (1 µM, 6 h) 
 
Perturbations of Ca2+ homeostasis are not linked to p53 transcriptional activity 
In order to exclude that a transcriptional-dependent pathway of p53 accounts for its effect on Ca2+ 
homeostasis (and in turn to the sensitivity of ER-stress apoptotic stimuli) we used both specific 
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drugs blocking the transcriptional arm of p53 and a nuclear import-deficient p53 mutant (p53-NLS). 
We used α-amanitin, a highly specific and potent inhibitor of the RNA polymerase II transcription, 
or a combination of pifithrin α, a specific inhibitor, which selectively blocks p53-mediated 
transcription and Adriamycin to activate the remaining p53 pathways. As expected, in both 
conditions we observed increased mitochondrial Ca2+ responses (Fig 17A), reflecting an increased 
ER Ca2+ release (p53+/+: peak 79.6 ± 13.8 µM, p53+/++ α-amanitin: peak 110.3 ± 12.1 µM and 
p53+/++ pifithrin α + ADRIA: peak 99.6 ± 5.8 µM).  
Moreover, over-expression of the p53-NLS chimera in p53-/- MEFs (Fig.17C) as well as in HeLa 
(Fig.17D), H1299 non-small lung carcinoma cells (Fig.17E) and HCT-116 p53-/- (Fig.17F), was 
able to enhance mitochondrial Ca2+ signaling, similarly to the effect of p53 induction by 
Adriamycin (Fig 15B). On the contrary, naturally occurring mutants of p53 over-expressed in those 
cell lines lost their ability to increase ER Ca2+ loading (Fig.17 D, E, F blue and grey dotted lines) 
(MEFs peak 35 ± 6.8 µM in p53-/- vs 65.5 ± 10.6 µM in p53-/- + p53-NLS; HeLa control: 40.1 ± 14 
µM, p53-NLS peak: 60.5 ± 10.3, p53 R175H peak: 37.7 ± 11.2 µM, p53 R273H peak: 36.8 ± 6.2 
µM; HCT116 ko control peak: 2.1 ± 0.2 µM, p53-NLS peak: 4.81 ± 0.3, p53 R175H peak: 2.4 ± 
0.45 µM, p53 R273H peak: 2.7 ± 0.41 µM; H1299 control peak: 0.43 ± 0.06 µM, p53-NLS peak: 
0.67 ± 0.07, p53 R175H peak: 0.5 ± 0.17 µM, p53 R273H peak: 0.5 ± 0.23 µM. n=12 from three 
independent experiments and p<0.05). 
To verify if the regulation of Ca2+ homeostasis by p53 depends on its localization to the ER/MAMs, 
we generated a chimera containing the p53-NLS protein targeted to the outer surface of the ER by 
the addition of the short hydrophobic C-terminal ER-targeting sequence cloned from the yeast 
UBC6 protein (162) (Fig.18A).  
The introduction of ER-p53 in p53-/- MEFs (Fig.18B) and in H1299 cells (Fig.18D) restored Ca2+ 
signals evoked by agonists to values comparable to those obtained after over-expression of the p53-
NLS chimera (MEFs, [Ca2+]m peak 40.6 ± 8.7 µM in p53-/- vs 81.5 ± 15.6 µM in p53-/- + ER-p53; 
H1299, ER-p53 chimera: 0.75 ± 0.08 µM; control: 0.41 ± 0.08 µM, as well as in wt MEFs after 
adriamycin induction (Fig.17C and 15B). This effect was moreover associated with a re-established 
sensitivity to apoptosis induced by ER stress, as determined by cell count analysis (Fig.18E) and 
PARP cleavage (Fig.18F). 
A mechanism proposed for p53-dependent cell death is through a transcription-independent 
pathway involving the Bcl-2 family (163) and in particular Bax/Bak proteins (122, 164) that 
localize also at ER (165). To evaluate whether the role of p53 at ER/MAMs in ER stress-dependent 
cell death stimuli requires Bax/Bak proteins, we analyzed the effects of p53 induction in cells 
deficient of Bax and Bak (DKO cells). In these cells, Adriamycin still raised [Ca2+]m (Fig.18C) thus 
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suggesting a mechanism independent from the Bax/Bak proteins.  
 
Fig.17 Alteration of Ca
2+
 homeostasis after p53 induction is Human Tumour cell lines (A-C) Measurements of 
[Ca
2+
] using recombinant aequorin upon agonist (100 mM ATP) stimulation in ER (A), mitochondria (B) and cytosol 
(C). (D) Isosurface rendering of representative p53
+/+ 
and p53
-/- 
MEFs expressing mitochondrial GFP in basal 
conditions, after ADRIA and/or H2O2 exposure. (E) Mitochondrial Ca
2+
 response ATP dependent in p53
+/+ 
(F) Analysis 
of [Ca
2+
]m during oxidative stress upon H2O2 stimulation (2 mM). 
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Fig 18 Transcriptional path of p53 is not required for perturbation of Ca
2+
 homeostasis. (A) Agonist-dependent 
[Ca
2+
]m response in p53
+/+
 MEFs after pharmacological block of transcriptional arm of p53. N=12 from three 
independent experiments and p<0.05. (B) Immunofluorescence of p53
-/- 
cells expressing p53-NLS stained with the anti-
p53 antibody and Hoechst (as nuclear marker). [Ca
2+
]m in p53
-/- 
MEFs (C) after over-expression of p53-NLS, and during 
overexpression of naturally occurring mutants in HeLa (D) HCT116 p53
-/-
 (E) and H1299 (F) compared with p53-NLS.  
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p53 promotes SERCA activity 
The above findings clearly suggest that the localization of p53 at ER/MAMs compartments is 
important for a Ca2+-mediated, transcription-independent apoptotic pathway and that it exerts its 
major impact on ER Ca2+ uptake, a process mediated by the SERCA, i.e. Sarco-Endoplasmic 
Reticulum Ca2+-ATPase. Thus, we tested whether p53 functionally and physically interacts with 
SERCA. As shown in Fig.18A, the in vitro interaction between p53 and endogenous SERCA2b was 
first detected by MBP pull down assay in H1299 cell line lacking of p53, after over-expression of a 
p53 wt construct and then confirmed by the co-precipitation in MEFs wt (Fig.19E) 
Next we mapped the region of p53 involved in the interaction with SERCA 2b. To this end, we took 
advantage of HA-tagged p53 deletion constructs: HAp53 1-175, HAp53 175-393, HAp53 294-393 
and the full-length HA-p53. In immunoprecipitation experiments performed in H1299 cells 
transfected with various HA-p53 constructs, SERCA2b selectively bound to the C-ter regulatory 
domain of p53, i.e. a region where post-translational modifications can modify the interaction of 
p53 with partner proteins (Fig.19B).   
Finally, we investigated whether p53 has a direct effect on the activity of SERCA pump. For this 
purpose, the kinetics of ER Ca2+ accumulation were studied in MEF wt and p53 null as well as after 
p53 induction by adriamycin in a time-dependent manner. The rate of Ca2+ accumulation in the ER 
increased proportionally to the induction of p53, indicating a stimulatory role of p53 on SERCA 
activity (Fig.19C) (MEFs. p53-/-: µM[Ca2+]/s 3.73 ± 0.11, n = 7; p53+/+: µM[Ca2+]/s 6.71 ± 0.6, n = 
14; p53+/+ ADRIA 30min: µM[Ca2+]/s 7.76 ± 0.82, n = 13; p53+/+ ADRIA 3h: µM[Ca2+]/s 8,81 ± 
0.45, n = 21; p53+/+ ADRIA 6h: µM[Ca2+]/s 9,31 ± 1.15, n = 15; from at least three independent). 
SERCA expression levels were unmodified, further excluding a transcriptional mechanism 
(Fig.19F). This data was confirmed also in HeLa cells over-expressing p53 wt and p53-NLS 
chimera (Fig.19D)(control, µM[Ca2+]/s 4.15 ± 0.23, n = 8; over-expression of p53 wt µM[Ca2+]/s 
8.05 ± 2.1, n = 8; and p53-NLS µM[Ca2+]/s 9.4 ± 3.1, n = 8).  
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Fig.19.  p53 modulates Ca
2+
 signals interacting with SERCA 2b pump. (A) In vitro binding of endogenous SERCA 
2b to MBP-p53. Lysates of H1299 cells were incubated with bacterially expressed MBP-p53 protein or MBP as control. 
Ponceau staining shows the amount of MBP proteins used in the experiments. (B) Full length and HA-tagged p53 
deletion mutants transiently expressed in H1299 cells were immunoprecipitated by anti-HA 12CA5 antibody and 
analysed by western blots with anti-HA 12CA5. Co-immunoprecipitated SERCA 2b proteins were analyzed with 
SERCA 2b antibody. (C) Rate analysis of Ca
2+
 refilling in the ER at different time of ADRIA treatment (1µM) in 
MEFs. P53
-/-
 and in HeLa Cells during overexpression of wt-p53 and p53-NLS (D). (E) immunoprecipitation assay 
revealing interaction between p53 and SERCA2b in MEFs. (F) Analysis of SERCA 2b levels in MEFs by western blot 
in presence or absence of activated p53. 
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Discussion 
 
From the early years after its discovering p53 has been always linked to molecular oncology. 
Initially described as a transcription factor has been addressed as a master gene involved in control 
of several processes that goes from promotion of apoptosis, regulation of autophagy, block of cell 
cycle, DNA damage repair, regulation of metabolism with final aim to inhibit tumour appearance 
and progression. Just recently has been proposed that p53 has important cytoplasmic activity, 
specially has been demonstrated how p53 could undergoes through monoubiquitinilation that drives 
its localization to mitochondria in order to induce MOMP and release of Cyt C, with subsequent 
activation of caspase 9 and apoptosis induction (166). Even more interesting this event appear to 
occur before of its nuclear translocation (167). After these initial reports several others appears, 
indicating how mitochondrial p53 localization could be mediated by a huge amount of cell stressing 
events (168). 
Nonetheless, most of these reports are based on biochemical protocols that allow obtainment of 
mitochondria enriched fractions that are prone to artefacts, allowing enrichment of other 
membranes, especially from endoplasmic reticulum. Known the close association between 
mitochondria and ER we investigated in this study if p53 could also localize to ER and especially to 
its contact sites with mitochondria, also known as MAM. 
We start the investigation by isolating mitochondria pure fraction, ER pure and MAM with 
subcellular fractionation in two different cell types Mouse Embryonic Fibroblast (MEF) and Human 
colon cancer cells (HCT116). Interestingly we found p53 able to localized to the ER and MAM 
fractions in both cell types, and specially, in HCT116+/+ the p53 stabilization promoted by a 
genotoxic stress, Adriamycin, induce a further accumulation of the protein. On opposite we almost 
not detected p53 in the mitochondrial fraction. 
Known the relevance for p53 in the apoptotic process we tested if, from this site, the same relevance 
could be maintained. Endoplasmic Reticulum participates in the apoptotic process by a special 
communication between mitochondria and ER. Several apoptotic stimuli in fact are able to induce a 
slow and sustained Ca2+ release from the ER that is capted by mitochondria allowing mitochondrial 
swelling and Cyt C release. Was though relevant to investigate if p53 could participate in such kind 
of processes. Wt and p53 ko cells were then challenged with two oxidizing factors (Menadione and 
H2O2) that allow the previously described calcium transmission and observed that ko cells appear 
strongly resistant compared to wt indicating p53 as a possible participant in the Ca2+ dependent 
apoptotic process. 
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To provide a causal link we start monitoring general Ca2+ homeostasis taking advantage of the 
calcium sensitive luminescent reporter aequorin targeted to the different cell compartments 
involved in this transmission, cytoplasm, mitochondria and ER. MEF wt in which p53 was induced 
by Adriamycin display a higher concentration of both [Ca2+]m and [Ca2+]c when Ca2+ waves were 
induced by extracellular ATP. Contemporary [Ca2+]er display a significant increase during the 
steady state, suggesting that alterations of Ca2+ waves where due to an increased amount of calcium 
within the ER. As expected ko cells display a reduced steady state within ER as also reduced 
calcium waves within cytoplasm and mitochondrial uptake.  
Moreover an increase in mitochondrial uptake was observed in HeLa cells expressing wt p53 as 
also in HCT116 exposed to Adriamycin. These data strongly indicates that Ca2+ content within ER 
is linked to the presence of p53 and that this event is reproducible not only in primary cultures but 
also in tumor derived cell lines. Interestingly MDA-MD 468 cells, derived from breast cancer, do 
not show significant alterations in [Ca2+]m after exposure to Adriamycin. Peculiarity of this cell line 
is the fact that they carry a mutant allele for p53, the R273H that is considered one of the hot spot 
mutations for p53. This mutation has been mapped within the DNA-binding domain of p53 and one 
of the most frequent in tumours associated with p53, enforcing the link between the p53 
proapoptotic activity and a transcription independent activity. 
Then was monitored the direct impact of p53 on mitochondrial calcium overloading and 
fragmentation. It is assumed from literature that mitochondria can undergoes through Ca2+ overload 
during Ca2+ dependent apoptotic stimuli that induce fragmentation of the mitochondrial network 
before to induce Cyt C release, even if it still under debate which are the molecular participant 
involved. In MEF wt pretreatment with Adriamycin do not significantly alter mitochondrial 
network interconnectivity without induction of apoptosis, on opposite it strongly promote 
appearance of round mitochondria, in spite to elongated, during H2O2 exposure. Contemporary, 
calcium accumulation within mitochondria (monitored with aequorin), elicited by H2O2 appear, 
longer and with higher amplitude in cells pre-treated with Adriamycin, reflecting an increased 
amount of Ca2+ released from ER. 
A direct link between p53 localization to ER and MAM was anyway still missing. To address this 
question [Ca2+]m was monitored during conditions non-permissive for transcriptional activity of 
p53. Administration of α-amanitin, an inhibitor of RNA polymerase II induce blockage of mRNA 
transcription and an indirect activation of cytoplasmic p53 (169). In wt MEFs a-amanitin was able 
to promote mitochondrial Ca2+ accumulation, and stabilization of p53 with Adriamycin still produce 
the same effect in presence of pifitrin-α, a well known inhibitor only of the transcriptional activity 
of p53. Similarly the overexpression of p53-ΔNLS, a chimeric p53 in which the nuclear export 
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sequences were mutated or deleted promote the same effect as wt p53 in cells ko for p53 both from 
primary cultures, MEF p53 -/-, as derived from human tumours, H1299, HeLa, HCT116-/-. Clearly 
suggesting that the transcriptional arm of p53 activity is not required for alteration of Ca2+ 
homeostasis. 
These data resemble what observed in MDA-MD 468, for long time p53 has been reported only as 
transcription factor, due to this the hot spot mutations naturally occurring in tumours, mapped in the 
DBD, has been addressed to the loss of transcriptional activity. Here we report a new non-
transcriptional role for p53 in the regulation for apoptosis. Nonetheless overexpression of p53-
R175H and p53-R273H, both carrying natural occurring mutants, were again able to elicit increase 
in mitochondrial calcium uptake in cells derived from tumour and KO for p53. Should be noticed 
that recently the same mutation has been mapped in newly defined interaction sites for Bcl-2 (170). 
The Bcl-2 route of p53 activity has been taken into consideration in literature to explain the 
mitochondrial activity of p53. Bcl-2 at the OMM bound to BAX and BAK impeding their 
oligomerization and the formation of permeability transition state that should allow Cyt C release. 
Current opinion is that p53 interacting with Bcl-2 sequesters it from OMM allowing 
oligomerization of BAX/BAK the Cyt C release. 
Here we provide that what observed to now be not linked to this mechanism. First of all should be 
considered that Bcl-2 also localize to ER, thus its interaction with p53 would promote its 
localization to the ER, second, we performed experiments of [Ca2+]m measurement in MEF 
BAX/BAK ko and observed that in such cells Adriamycin was still able to promote calcium uptake, 
third, we generated an ER targeted p53 chimera fusing p53-ΔNLS to an ER localization sequence 
from the yeast ubiquitin ligase UBC6. Overexpression of this chimera in MEF-/- as well as in H1299 
was able to both induces the expected alteration of Ca2+ homeostasis as well as on sensitivity to cell 
death. 
Last point was investigation of the molecular mechanism by which p53 is able to alter Ca2+ 
homeostasis at the ER. Measurements of Ca2+ homeostasis shows a difference in the kinetic of Ca2+ 
uptake within the ER, in the initial part of the experiment, when extracellular calcium where added. 
Usually this event is regulated by activity of SERCA protein, a Ca2+ ATPase located to the ER 
membrane that constantly pump Ca2+ within the ER lumen. Calcium uptake rate was increased in 
HeLa cells Expressing both p53 wt and p53-ΔNLS, moreover in MEF wt correlate directly with the 
time of exposure to Adriamycin. 
Through co-immunoprecipitation assay we observed that p53 is able to interact with isoform 2b of 
SERCA in MEF wt. We next generated p53 fragment to isolate the domain of interaction. GST 
pulldown assay revealed, in H1299 that the p53 is able to interact with SERCA2b through a region 
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out of its DBD, between its oligomerization domain and the regulative domain. Apparently the 
interaction domain is outside from its DBD, far from the hot spot sites, indicating that these sites are 
not directly involved in interaction with SERCA. This suggests that interaction between SERCA 
and p53 is mediated by other proteins. A second possible explanation is that several hot spot 
mutation, even if occurring within the DBD, are reported to induce a deformation in p53 structure 
(171). That in turn could induce a loss of interaction with SERCA-2b even if located far from the 
DBD. 
Overall these data reveal a novel mechanism through which p53 exerts its potent pro-apoptotic role. 
We demonstrate that the non-nuclear fraction of p53 is present in the ER/MAMs fraction and 
physically interacts with SERCA, thus potentiating Ca2+ accumulation in the ER lumen. This allows 
apoptotic stimuli and ER stress conditions, to rapidly and efficiently load mitochondria with Ca2+, a 
priming step for the release of caspase cofactors and induction of apoptosis via the intrinsic 
pathway. In cancer cells this pro-apoptotic mechanism could be impaired due to functional 
inactivation of p53 and contribute to the disease progression. The identification of the critical 
signalling steps activating this new function of p53 may provide new targets to restore sensitivity to 
cell death and develop new therapeutic approaches. 
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Tumour necrosis factor alpha inhibits oligodendrocytes 
differentiation by inhibiting mitochondrial functions 
 
Introduction   
 
Multiple sclerosis (MS) is a neurological disorder of the central nervous system characterized by 
demyelination and neurodegeneration. MS is characterized by its relapsing-remitting course and 
neuro-pathologically manifests with multifocal areas of perivascular leukocyte infiltration 
associated with demyelination of the CNS. Early clinical symptoms result from oligodendrocytic 
damage and/or demyelination. The regression of symptoms is attributed to resolution of immune-
based attack, associated edema and to partial remyelination or redistribution of sodium channels 
along demyelinated segments of axons (171). Although the pathogenesis of MS is not completely 
understood, various studies suggest that immune-mediated losses of myelin and mitochondrial 
dysfunction are associated with the disease (172). In particular, mitochondrial functions might be 
required for proper oligodendrocyte differentiation and myelination. Specifically, it has been 
demonstrated that i) mitochondrial transcripts and copy number are induced by oligodendroglia 
differentiation, ii) slight mitochondrial inhibition inhibits differentiation, and iii) stronger 
mitochondrial inhibition selectively decreases viability of differentiating oligodendroglia but not 
undifferentiated cells (173). 
It is now well established that mitochondria play a pivotal role in cell survival in large part because 
of their participation in the dynamic regulation of cellular Ca2+. Under normal conditions, the 
accumulation of Ca2+ in mitochondria stimulates oxidative metabolism. However, overload of 
mitochondria with Ca2+, as a consequence of pathological stimuli, results in dramatic alterations in 
mitochondrial functions, including decreased ATP production and increased generation of reactive 
oxygen.  For example, compounds generated in response to inflammation (e.g., reactive oxygen and 
nitrogen species) inhibit mitochondrial electron transport, resulting in axonal energy deficits (174, 
175). Recent reports have documented impaired activity of several mitochondrial respiratory 
complexes in MS plaques (176). 
Oligodendrocytes are particularly susceptible to oxidative injury. Having a low concentration of the 
antioxidant glutathione predisposes these cells to the accumulation of intracellular hydrogen 
peroxide. Contributing factors include their high metabolic rate and ATP requirement for the 
synthesis of large amounts of myelin membrane, the high production of hydrogen peroxide in 
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peroxisomes, and the large intracellular stores of iron. Whereas iron is critical for myelin production 
(177), this metal can also trigger free radical formation and lipid peroxidation, via conversion of 
hydrogen peroxide into hydroxyl radicals (178). Microglia present at the sites of injury play an 
important role in triggering or potentiating oligodendrocyte injury by several mechanisms. Both 
resting and activated microglia may release glutamate via a cystine-glutamate antiporter (179) as 
well as proinflammatory cytokines, such as tumour necrosis factor (TNFα), which impair 
expression or function of glutamate transporters in astrocytes and oligodendrocytes. TNFα can also 
trigger oligodendrocyte apoptosis both via death receptors and by activation of sphingomyelinase, 
with consequent release of ceramide (180). There is in vitro evidence that cytokine-induced 
oligodendrocyte injury may be mediated by iron and involves mitochondrial dysfunction (178) 
Evidence that implicates TNFα in the underlying pathology of MS includes: i) the observation that, 
at autopsy, MS patients have elevated TNFα levels at the site of active MS lesions (181); ii) reports 
that CSF and serum TNFα levels in individuals with MS are elevated compared to unaffected 
individuals and TNFα levels correlate to the severity of the lesions [(182),(183)]; and iii) evidence 
that peripheral blood mononuclear cells from MS patients just prior to symptom exacerbation have 
increased TNFα secretion after stimulation compared to cells from the same patients during 
remission (184). Based on these strong clinical parameters implicating TNFα signalling in 
contributing to MS disease severity, the effects of manipulation of the TNFα pathway were 
investigated in mouse models of MS. Specifically, overexpression of TNFα leads to demyelinating 
disease and neutralization of TNFα with anti- TNFα antibodies or receptor fusion proteins is 
protective in experimental autoimmune encephalomyelitis (EAE) transgenic mouse models (185). 
Oligodendrocyte progenitors upregulate both TNFR1 and TNFR2 in response to inflammatory 
conditions, indicating that the proliferative effect of TNFα may be directly mediated through these 
receptors (186). In most reports, the exacerbating effect of TNFα is attributed to TNFR1, whereas 
TNFR2 is shown to have little or no effect on demyelination (187),(188),(189). 
It has been shown that TNFα signalling through TNFR2 promotes the accumulation of proliferating 
oligodendrocyte progenitors, which then develop into mature oligodendrocytes required for 
remyelination. These results have a significant effect on the promotion of oligodendrocyte precursor 
growth and remyelination in vivo and in vitro, and the treatment of demyelinating diseases.  
TNFα may promote early pathology, but its actions appear to be more complex than just induction 
of cell death. In fact, using mice lacking TNFα and its associated receptors, an unexpected role for 
TNFα and TNFR2 in repair of the CNS has been reported. This role of TNFα expands its known 
function in proper organogenesis and indicates a critical involvement in the timely production of 
oligodendrocyte precursors and mature oligodendrocytes in the CNS. Indeed, the lack of TNFα and 
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TNFR2 leads to a significant reduction in oligodendrocytes due to a delay in the generation of these 
cells (190). 
To date it is widely reported how TNFα is able to impair oligodendrocytes differentiation. At low 
concentration TNFα has been shown to induce retardation in appearance of adult oligodendrocytes 
in vitro, while at higher concentration it appear to be able to induce also cell death (191). 
Moreover, in leukemic cell lines, TNFα induced cell death requires the impaired activity of 
Complex I of the mitochondrial respiratory chain, NADH dehydrogenase, strategic for the 
regulation of ATP synthesis, as well as being one of the most important sources of ROS within 
cells. 
In this study we address the possibility that TNFα a impairs oligodendrocytes differentiation by 
impairing mitochondrial physiology and further we evaluate the possibility that this impairment 
involve mitochondrial calcium signalling. 
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Results  
 
TNFα at distinct concentrations impair oligodendrocyte differentiation or cell death 
The first point considered was the ability of TNFa to impair oligodendrocytes differentiation in our 
in vitro system, set up following the protocol published by Chen et al (192). Oligodendrocyte 
progenitor cells (OPCs) were obtained by overnight shaking of mixed glial cultures generated from 
rat cortex. Isolated OPCs were then cultured for 7 days in presence of a selective chemically 
defined DMEM (OPC medium). Immunostaining with marker for total oligodendrocytes population 
(OSP), oligodendrocyte precursors (NG2), marker of fully differentiated oligodendrocytes (MBP) 
and marker of astrocytes (GFAP) were performed to verify the purity of the culture, assessed at 
about 95% of OPCs (data not shown). After 7 days of culture OPCs where treated for 24h with 
sublethal concentration of TNFa, 10ng/ml, as suggested by literature (193). Subsequently the 
growth factors present within the medium (fundamentals for OPCs replication) were substituted 
with T3 thyroid hormone to stimulate cell differentiation. After 5 days cells where fixed and 
immunostained for antigens able to mark different stages of oligodendrocytes maturation. 
According to the literature three different antigens were selected for three stages of differentiation: 
NG2 chondroitin sulphate proteoglycan for precursor, O4 for immature oligodendrocytes and MBP 
for fully differentiated (194). All the cells were contemporary stained for the oligodendrocytes 
specific antigen OSP to restrict the analysis only to the oligodendrocytes population and avoid 
artefacts coming from any contaminants. Cells were then acquired through an image based high 
content throughput system and classified by antigen positivity and nuclear features. During 
differentiation process in fact oligodendrocytes undergoes through deep rearrangement of cell and 
nuclear shape, specially nuclei increase their volume while reaching adulthood (Fig.20A). 
Assay reveal that low TNFα concentration induce a reproducible reduction in MBP+ and O4+ cells 
%, with concomitant slight increase in NG2+ %, suggesting that an early block in the differentiation 
process was occurring. (control NG2+:34.2% ± 3.67, O4+:51.85% ± 2.01, MBP+:16.75% ± 5.58; 
TNF 10ng/ml: NG2+:39.05 % ± 1.06, O4+:42.7 % ± 2.35, MBP+:8.75 % ± 0.49. n:4 p<0.05.) 
Unexpectedly at high concentration no significant variation were observed (Fig.20B). (TNF50ng/ml 
NG2+:33.8% ± 5.06, O4+:43.73% ± 2.85, MBP+:13.83% ± 5.84; TNF 100ng/ml: NG2+:35.45% 
±2.47, O4+:48.23% ± 0.87, MBP+:17.63% ± 0.94. n:4 p<0.05.) 
Further we tested the ability of TNFα to induce cell death. Cells were growth, exposed to TNFα 
and induced to differentiate as described previously. After fixation, cells were stained for a TUNEL 
assay. This technique is based on an enzymatical incorporation of fluorescence labelled 
deoxynucleotide in DNA breaks in nuclei (195) making it very sensitive for identification of 
 63 
apoptotic nuclei. TUNEL assay reveal that only at high concentration TNFα was able to promote 
apoptosis, moreover the effect appear generalized in all the populations, explaining why no relative 
enrichment of some populations were observed (Fig 20C). (control 6.28% ± 3.69; TNF10ng/ml 
7.43%±1.85, TNF50ng/ml 11.14%±3.89, p<0.1; TNF100ng 13.51±3.36, p<0.05 n>6). 
Taken toghether these data support the hypothesis that at low concentrations TNFα is more able to 
affect oligodendrocytes differentiation, causing a block in very early stages with a consequent 
accumulation mostly of NG2+ oligodendrocytes. On opposite, higher TNFα concentration cause an 
increase of apoptosis induction. 
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Fig.20. Distinct cell response initiated by TNFα .  Nuclear pattern for scoring OPCs (Ai) or Adult Oligodendrocytes 
(Aii) and typical immunostaining for antigens used to score oligodendrocytes populations.  (Β)  Oligodendrocytes 
enrichment for precursor (i), immature (ii) and adult cells (iii) during different concentration of TNFα. (C) Tunel assay 
in Oligodendrocytes populations during exposure to TNFα 
 
 65 
Low concentration of TNFα  selectively impair mitochondrial Ca2+ uptake 
Second part was to consider mitochondrial physiology under TNFα exposure. As previously 
discussed mitochondrial calcium uptake could be considered as an affordable readout for monitor 
mitochondrial physiology. It is infact true that calcium is uptaken by mitochondria through the 
driving force provided by ∆Ψm  at the site in which mitochondria take contact with the ER. Once 
entered into mitochondria, calcium flow within the entire network because of the high amount of 
dynamic interconnections existing between mitochondria into the same cell. Noteworthy both ∆Ψm  
and mitochondrial interconnectivity (or fragmentation) could be considered readout of mitochondria 
energy status, as well as exposure to stress or apoptosis induction. 
Thus to monitor mitochondrial physiology under TNFα exposure we tested their ability to uptake 
calcium following agonist exposure. To this attempt OPCs where infected with an adenoviral vector 
carrying cDNA for mitochondrial targeted mutant aequorin, 24h post infection cells were exposed 
to different TNFα concentrations (as previously described) and at 24h of TNFα exposure aequorin 
measurements were performed. 
We elicited Ca2+ waves by stimulation with Carbachol (CCH) that after binding on its muscarinic 
receptor expressed on OPCs surface (196) was able to induce IP3 generation and Ca2+ release from 
ER stores. 
CCH stimulation induce a rapid increase in [Ca2+]m in OPC, measured at 53.64 µM (n:6, ± 6.73) 
that recover to basal levels within one minute (Fig.21A). On opposite TNFα exposure was able to 
reduce mitochondrial calcium accumulation showing stronger effect at low concentration, [Ca2+]m 
values are reported as follow:  
 
TNFα  concentration 
(ng/ml) 
Measured [Ca2+]m 
(µM) 
SD P value 
% variation VS 
control 
10 29.35 10.35 0.00035 
 
-45.27 
50 37.53 11.39 0.00904 -30.03 
100 48.62 13.30 0.07449 -9.46 
 
The most interesting observation is linked to the complete absence of a proportional dose response 
dependency.  
Nonetheless what has been considered more interesting for prosecution of investigation is the 
observation that when TNFα is already able to impair differentiation without sensibly affecting 
apoptosis, is also able to induce a strong effect on mitochondrial physiology, while with 
instauration of clear apoptosis induction the effect on mitochondrial physiology become 
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progressively attenuated. Based on this observation is the choice to further investigate only the 
effects elicited by TNFα 10ng/ml. 
To further address the events linking altered mitochondrial physiology to calcium uptake we 
investigated whether TNFα was able to affect global Ca2+ signalling homeostasis. We tested this 
hypothesis by performing the previous experiments but measuring cytosolic Ca2+ responses using 
aequorin located in the cytosol (cytAEQ). As shown in Fig.21B, in control cells carbachol rapidly 
and transiently increases cytosolic Ca2+ concentration ([Ca2+]c) reaching maximum values (1.82 ± 
0.08 uM, n=25) similar to those detected in OPC pretreated with 10 ng/ml for 24h (1.72 ± 0.09 uM, 
n=25, p>0.05), indicating that the observed effects were restricted to mitochondrial physiology. 
We then investigated the effects of IFNgamma (INFγ) on mitochondrial Ca2+ homeostasis. It is in 
fact well know how this cytokine, as for TNFα, is able to mediate inflammation execution during 
Multiple Sclerosis and other demyelinating disorders. OPC were treated with IFNγ 20 ng/ml for 
24h, then mitochondrial Ca2+ variations elicited by agonist stimulation were investigated. As shown 
in Fig.21C, no significant difference in [Ca2+]mt was observed between IFNγ treated and control 
cells (peak amplitude 79.7 ± 5.14 uM vs 89.4 ± 5.74 uM, n = 16; p > 0.05). Suggesting that a 
special binomial exist between TNFα and mitochondrial physiology. 
We then investigated whether TNFα affects mitochondrial Ca2+ homeostasis in other glia cell types, 
such as astrocytes. 
To address this issue, we analyzed [Ca2+]mt in astrocytes obtained from the same cortex culture used 
for the growth of oligodendrocytes. As described in the protocol of Chen, a dissectioned rat cortex 
is seeded in a 75ml flask and cultured for 10 days permitting oligodendrocytes to growth on an 
astrocytes layer. This layer could be detached by trypsin exposure and seeded onto a coverglass for 
aequorin measurements. The elevated abundance of astrocytes from this mixed glia culture yields a 
culture almost pure in astrocytes. Interestingly, contrary to our previous observations in OPC, in 
astrocytes (Fig.21D) treatment with TNFα caused a significant increase in [Ca2+]mt transients 
evoked by agonist stimulation (peak amplitude 52.6 ± 3.1 mM treated vs 42 ± 3 mM control, 
p<0.05, n=26). 
In summary we observed that TNFα is able to perturb [Ca2+]m in OPCs only at concentration non-
permissive for efficient apoptosis initiation. Contemporary these variations were not reproducible 
neither by INFγ nor in other glial cells, suggesting a selective and fine regulated link between 
mitochondria and TNFα in OPCs. 
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Fig.21. TNFα  selectively impair mitochondrial physiology in oligodendrocytes progenitors. Mitochondrial Ca2+ 
measurement in OPCs during agonist stimulation at different TNFα exposure (A) or INFγ (C). Cytoplasmic waves in 
OPCs during low concentration TNFα exposure. Effect of TNFα on Mitochondrial Ca
2+
 response in astrocytes. 
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TNFα  impairs mitochondrial bioenergetics and promote Superoxide production 
To clearly define how TNFa was able to promote mitochondrial impairments observed measuring 
[Ca2+]m we monitored ∆Ψm  and network integrity. 
Electric potential is generated across inner mitochondrial membrane due to the activity of 
respiratory chain that consumes oxygen to pump protons to the intermembrane space. This proton 
gradient will be used by ATP synthase to drive ATP synthesis. ∆Ψm  could be easily monitored by 
fluorescence microscopy trough the use of different selective dyes. In our case we performed the 
measurement through the use of the potential sensitive dye TMRM and laser scanning confocal 
microscopy. Cells were treated with TNFα 10ng/ml or vehicle for 24h, loaded with TMRM 10nM 
then acquired before and after FCCP depolarization. The delta value induced by mitochondrial 
depolarization were considered as index of ∆Ψm  and compared between TNFα exposed cells and 
controls. The results evidentiate a strong ∆Ψm  reduction, of 30.5% (S.E. ±9.76), in cells treated 
with TNFα, suggesting an important decrease of respiratory chain activity (Fig.22A). 
Subsequently we measured alterations of mitochondrial structure through digital deconvolution 
microscopy. OPCs were infected by adenoviral vector carrying cDNA for mitochondria targeted 
GFP, then acquired by fluorescence microscopy at high magnification, deconvolved and 
reconstructed in 3D images. Number and mean volume of mitochondria per cells were obtained and 
compared between TNFα exposed and control oligodendrocyte. Total network volume per cells is 
about 40837,4 voxels (S.D. ±12213,18) in control and 43501 voxels (S.D. ±6463,33) in TNFα 
treated cells (Fig.22Bi), while volume for single mitochondrion was 121,35voxel/object (S.D. 
±382,88) in control and 922,69voxel/object (S.E. ±183,17) in TNFα (Fig.22Bii). Nor total network 
volume neither single particle volume result significantly different between conditions. 
These results addressed the previous observed reduced [Ca2+]m as a consequence of impaired ∆Ψm . 
It has been reported how impairment of respiratory chain could alter ROS metabolism leading to 
different ROS generation, nonetheless TNFα itself has been shown to stimulate the same effect. 
Electron leak from respiratory chain has been reported mostly to promote generation of superoxide 
anion, that is mainly reversed to mitochondrial matrix and partly into the inter membrane space 
(197). Due to effect of Super Oxide Dismutase, O2-. is rapidly converted to H2O2 then detoxified to 
H2O by catalase. Was in turn considered fundamental to monitor ROS production, three different 
fluorimetric approaches were used to obtain an overview of general ROS metabolism, based on 
three different ROS sensitive dyes: dichlorodihydrofluorescein (DCF), Dihydroethidium (DHE) and 
MitoSOX. 
DHE and MitoSOX are well known ethidium based O2-. Sensitive dyes, with the peculiar difference 
that could be selectively localized to cytoplasm and mitochondria respectively, while DCF is 
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generally used as sensor for H2O2. To perform this measurments cells where growth for 7 days in 
multiwells, then exposed to TNFα 10ng/ml for 24h, after treatment cells were stained and measured 
as further described (see materials and methods). Interestingly within all these three parameters only 
MitoSOX display significant variations (MitoSOX control 1336.64AFU± 255.06; TNF 10ng/ml: 
2397.71AFU± 560.73, n: 3 p<0.05; DHE control 7725.72AFU± 543.87; TNF 10ng/ml: 
7987.0AFU± 896.15, n: 3; DCF control 55.37AFU/s± 15.41; TNF 10ng/ml: 58.40AFU/s± 9.82, n: 
3 ). Considering that MitoSOX has high selectivity for mitochondrial O2-. we found this result linear 
with what previously observed (Fig 22C). 
In order to obtain a further comprehension the mechanism by which TNFα was able to produce this 
effect on ROS production we monitor expression of respiratory complexes by immunoblotting. 
Immunoreaction was performed with the OxPhos antibody cocktail that allow contemporary to 
monitor subunits in all the five respiratory complexes, specially the detectable targets are: NDUFB8 
for complex I, SDHB for complex II, UQCRC2 for complex III, MTCO1 for complex IV and 
ATP5A for complex V. As loading marker was choosed mitochondrial HSP60. 
The blot display a strong and almost selective reduction in marker for Complex I, even if weak 
alterations has been displayed for Complex II (Fig.22D).  
We consider the alteration of respiratory complex I level as the very basic effect able to induce all 
the other alterations observed ([Ca2+]m, ∆Ψm , and O2-. production). Considering that mitochondria 
undergoes to continuous processes of degradation and biogenesis, allowing old and damaged 
organelles recycling, as well as several mitochondrial features are transcriptionally regulated during 
stress conditions (198, 199) we tested if alterations in Complexes expression and ROS metabolism 
were maintained during differentiation or if oligodendrocytes undergoes trough adaption. 
Experiment were performed as for antigen recognition, briefly cells after 7 days of colture were 
exposed to TNFα 10ng/ml for 24h then placed in presence of T3 thyroid hormone and let 
differentiate for 5 days. At the and of this period cells were alternatively used for ROS measurments 
or immunoblotting. MitoSOX staining resulted yet higher in treated cells compared to control 
(Fig.21E), but higher variability was measured reducing the significativity of the result (MitoSOX 
control 644.71AFU± 107.81; TNF 10ng/ml: 2132.15AFU± 2085.7, n: 3). 
Interestingly immunoblot result obtained in the same conditions reveal that variations in expression 
levels of Respiratory Complex I still exist in adult oligodendrocytes as observed in OPCs (Fig.22F).  
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Fig.22. Perturbation of mitochondrial physiology mediated by TNFα  in OPCs. (A) Measurements of ∆Ψm  with 
potentiometric dye TMRM. (B) Representative volume rendering of control OPCs and TNFα treaated cells, (i) voxel 
quantification of total mitochondrial volume and (ii) single mitochondrial volume. Measurement of Superoxide in OPCs 
mitochondria (i) cytoplasm (ii) and measurement of H2O2 levels (iii). Expression of respiratory complex subunit in 
OPCs (D) and Adult (F), NDUF8B for complex I, SDHB, for complex II, UQCRC2 for complex III, MTCO1 for 
Complex IV and ATP5A for Complex V. HSP60 has been used as loading marker. Analisis of mitochondrial 
superoxide in adult cells (E). 
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Mitochondrial dysfunction mediated by TNFα drives impairment of oligodendrocytes 
differentiation. 
The results proposed to now shows a correlation between TNFα induced differentiation blockade 
and mitochondrial conditioning. Nonetheless a causal link between mitochondrial physiology and 
OPCs differentiation is still missing on this study. 
Initial step was to reproduce in control cells a condition that was able to reproduce the 
mitochondrial impairment generated by TNFα. To this attempt was choosed carbonylcyanide-p-
trifluoromethoxyphenylhydrazone (FCCP), a mitochondrial uncoupler able to induce proton leak 
trough the inner mitochondrial membrane leading to reduction of ∆Ψm . We used FCCP 500nM in 
substitution to TNFα in OPCs coltures, then we tested its toxicity (by cell count analysis, data not 
shown) and monitored ∆Ψm  through the potential sensitive dye TMRM and confocal microscopy. 
At this concentration FCCP was enough diluited to do not induce toxicity but able to reduce ∆Ψm  
of comparable entity to TNFα (Fig 23A). (control 867AFU ±150.60, FCCP 616 AFU ±83.97, 
TNF10ng/ml 655.02±68.96 n:3 p Vs control <0.05). 
We next test ability of progenitors to differentiate into adult oligodendrocytes during FCCP 500nM 
exposure. Again the result display high homology with results obtained in presence of TNFα. In fact 
at 5 days of differentiation we observed FCCP to reduced amount of O4+ and MBP+ 
oligodendrocytes, while increase the number of NG2 positive cells (control NG2+:57.13% ± 5.9, 
O4+:26.72% ± 9.36, MBP+:40.65% ± 21.85; TNF 10ng/ml: NG2+:67.9% ± 4.78, O4+:18.46% ± 
2.84, MBP+: 23.26% ±20.13. n:4 p<0.05.), suggesting that mitochondrial physiology are 
fundamental to drive initial phase of differentiation. 
Several reports suggested that mitochondrial calcium could be a strategical regulator of 
oligodendrocytes differentiation, specially different proteins involved in handling of calcium 
homeostasis and associated to mitochondria or to the mitochondria associated membranes has been 
reported has regulator of oligodendrocytes differentiation (200, 201), moreover the purinergic 
signal mediator ATP, that is able to elicit mitochondrial calcium uptake in oligodendrocytes, is also 
able to promote oligodendrocytes differentiation (194). 
We suppose that a possible explanation for FCCP ability in mimicking TNFα effect was due to an 
impairment of [Ca2+]m and perform experiments trying to promote mitochondrial calcium 
accumulation in presence of TNFα with the intention to revert phenotype on differentiation. 
We perform two different approach, one based on the MAPK inhibitor SB202190. This is a 
selective inhibitor of p38 MAPKa/b that display as potent aspecific effect the ability to promote 
activity of the mitochondrial calcium uniporter (202), with consequent strong promotion to 
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mitochondrial calcium uptake. In order to avoid inhibition of endogenous MAPK and given that its 
kd is 38 nM, we start using it at concentration of 1nM. 
After 24h of exposure to SB202190 cells display a weak increase in [Ca2+]m, around + 9%, but 
interestingly it was almost completely able to recover the calcium uptake reduction induced by 
TNFα (control, peak amplitude 71.48 ± 510.48 uM, TNF 10ng/ml 53.34 ±10.72 uM, SB202190, 
peak amplitude 74.15 ± 23.64 uM, SB202190 + TNF 10ng/ml 74.33 ±14.59 uM n = 8; p Vs 
TNF10ng/ml> 0.05). 
We next move to verify if SB202190 was contemporary able to recover the differentiation 
progression. Because the strongest differences were observed with NG2 and MBP markers 
(probably because are marker of the most extreme stages of differentiation) we perform a 
differentiation assay with only these two markers. 
Interestingly SB202190 alone was strongly able to increase the amount of NG2+ and reduce the 
amount of MBP+, even more powerful then TNFα itself. Also the contemporary administration of 
TNFα and SB202190 did not show any synergistic effects, the effect of the cytokine appear to be 
completely overcomed by SB202190 (Fig.23D). (control NG2+:64.55% ± 4.98, MBP+:38.75% ± 
8.12; SB202190 NG2+:77.85% ± 3.88, MBP+:26.075% ± 10.28; TNF 10ng/ml: NG2+:68.5% ± 
4.79, MBP+: 15.56% ±8.12; TNF + SB202190: NG2+:71.02% ± 2.32, MBP+: 18.04% ±15.75. 
n:3). 
In summary these results suggest that the mitochondrial impairment induced by TNFα is possibly 
fundamental for its mechanism, moreover a complex role for [Ca2+]m appear also to be present 
unless the present data are to able to unravel it. 
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Fig.23. Mitochondria energy state, but not calcium uptake is foundamental for OPCs differentiation. (A) 
Measurments of ∆Ψm  with potentiometric dye TMRM in OPCs exposed to FCCP 500nM or TNFα. 
(B) Oligodendrocytes enrichment for precursor (i), immature (ii) and adult cells (iii) during FCCP exposure. 
(C)Mitochondrial Ca
2+
 measurment in OPCs expose to TNFα, to SB202190 or in combination of both drugs. (D) 
Oligodendrocytes differentiation test in the same conditions. 
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Discussion 
 
It has been well established that the Tumour Necrosis Factor alpha is one of the most relevant 
cytokines involved in the pathogenesis of Multiple Sclerosis. In fact, it has been widely reported 
how the levels of this cytokine correlate with the exacerbation of the pathology as well as how it 
could affect the physiology of Oligodendrocytes (the principal target of degeneration during 
aetiology of MS) in vitro. This impairment is principaly manifested by the induction of cell death 
(at high concentrations) as also by blockage of their differentiation process. 
In this study we address the hypothesis, that impairment of differentiation due to TNFα exposure is 
linked to affected mitochondrial physiology. 
Initially, we confirmed that exposure to low concentrations of TNFα (10ng/ml) is able to impair 
OPCs differentiation. We observed an accumulation of NG2+ cells (early progenitors) while 
reducing the relative amount of O4+ and MBP+ (immature oligodendrocytes and adult 
oligodendrocytes respectively). This phenomenon was not accompanied by a significant induction 
of apoptosis. On the other hand, exposure to higher concentrations of TNFα, induced a strong 
increase in cell death, with no significant accumulation any specific oligodendrocytes population. 
This led to the hypothesis that TNFα is able to induce an immediate effect in the progenitor 
population that could generate two distinct outcomes: blockade of differentiation or induction of 
cell death. These data were in agreement with previously reported results (203). 
Basing on this hypothesis we tested whether at this early stage, TNFα was able to affect 
mitochondrial physiology. As an initial readout we chose to monitor mitochondrial Ca2+ uptake as  
it is often an initial reporter of alterations of mitochondrial physiology.  
We took advantage of the Ca2+ sensitive luminescent protein Aequorin, (targeted to mitochondria) 
to measure mitochondrial Ca2+ homeostasis in OPCs at an early stage of TNFα exposure. 
Interestingly we observed a significant reduction in [Ca2+]m only at a low TNFα concentration. This 
was in accordance with the “two destinies” hypothesis, suggesting that mitochondrial impairment 
was a specific event during the differentiation impairment process. The effect on mitochondrial 
homeostasis was confirmed by measuring cytoplasmic Ca2+ waves, with the use of a cytoplasmic 
aequorin. Cells treated with TNFα [10ng/ml] did not display any differences in cytoplasmic Ca2+ 
compared to controls, indicating that alterations in [Ca2+]m were not due to a general perturbation of 
the whole intracellular Ca2+ homeostasis. 
Next to TNFα, another cytokine, INFγ is well known to participate in the pathogenesis of MS. We 
have also addressed this cytokine to verify the cytotoxic effects on oligodendrocytes since no 
relations with the differentiation process have not yet been reported. We used subtoxic 
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concentrations of IFNγ [20ng/ml] to verify if perturbations of mitochondrial physiology could be 
considered a general activity of proinflammatory cytokines and we reported no significant variation 
in [Ca2+]m. 
But in order to properly be able to identify a selective relationship between TNFα and OPCs there is 
a need to test the [Ca2+]m also in other cell types, known to be sensitive to this cytokine. We found it 
interesting to monitor [Ca2+]m in astrocytes cultures, due to the huge amount of reports indicating 
how astrocytes sense TNFα and also participate to its metabolism (204, 205). 
We found that [Ca2+]m was strongly modified in TNFα-exposed astrocytes. However, instead of 
being reduced, as measured in OPCs, it was significantly increased. This suggests that a 
perturbation on mitochondrial physiology was occurring, but in an apposite direction and, 
presumably, involving different pathways. 
It appears clear that a selective cytokine-dependent and cell-dependent relationship exists between 
mitochondrial physiology and OPCs during TNFα exposure. 
To obtain a deeper comprehension about what this mitochondrial perturbation consists of, we 
measured the ∆Ψm and mitochondrial fragmentation during early TNFα exposure, considering them 
principal features linked to [Ca2+]m. Mitochondrial Ca2+ uptake is driven by the mitochondrial 
membrane potential, and is it’s direct function. Moreover, once in mitochondria, Ca2+ flows from 
the ingress sites (contact sites with endoplasmic reticulum) to the entire network. Due to these 
features, both, variations of ∆Ψm as well as of the mitochondrial network interconnections are 
reflected in alterations in average Ca2+ uptake. Interestingly while mitochondria in treated cells did 
not significantly change in neither size nor number, they displayed a significantly lower ∆Ψm. 
Variations of the ∆Ψm are often linked to impaired energy production as also to alterations of ROS 
metabolism. In particular, a strong elevation of ∆Ψm have been reported to lead to accumulation of 
different reactive species of oxygen. Moreover TNFα itself is a known ROS inducer in different 
cellular systems. 
To obtain a general overview of ROS metabolism we monitored production of both O2.- and H2O2 
with fluorimetric dyes. We were also able to distinguish between mitochondrial and cytoplasmic 
O2.- through the use of two different dyes (MitoSOX and DHE respectively), proper recognition of 
the two different amount of O2.- was fundamental to properly address the real source. It is well 
known that mitochondria are the site for the synthesis of a significant amount of O2.-, but it is also 
generated in large amounts in other organelles (206). What is more, O2.- has a very short half-life 
and is usually rapidly dysmutated to H2O2 by SODs, making the measurement of O2.-  difficult. 
Thus, to more precisely assess the overall contribution of ROS, it is crucial to also use other probes, 
such as DCF (to monitor H2O2). Interestingly, we found that only MitoSOX gave a significantly 
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higher staining in treated cells compared to control, suggesting that mitochondria were stimulated in 
O2.- production by TNFα. 
To date, the two most important mitochondrial sources for O2.- are both within the respiratory chain. 
They are respiratory complexes I and III. Impairment of their activity leads to rapid and robust O2.- 
production, with a peculiar difference. Complex I leave the O2.- produced within the mitochondrial 
matrix only, whereas complex III is able to generate it both in the matrix and the IMS (207). Since 
DHE is not able to distinguish between the cytoplasm and the IMS (due to high permeability of the 
OMM) and due to the different behaviour between MitoSOX and DHE we suggest an impairment 
of Complex I. Similar suggestions do arrive from the literature. In leukemic cells, TNFα was able to 
induce death by selectively promoting ROS by complex I (208), while in rat left ventricle TNFα led 
to a O2.--dependent reduction in Complex I expression (209). 
Through immunoblot we verified that OPCs treated with TNFα for 24h display a strong reduction in 
respiratory complex I subunit NDUFB8 and even more interestingly, the altered levels were 
maintained in adult cells during differentiation.  
Impairment of the transcript level of this complex could lead to the reduction of ∆Ψm measured in 
OPCs and gained our particular interest in light of the observed differentiation impairment. It was in 
fact reported that during differentiation, OPCs undergo to a deep rearrangement of expression of 
genes involved in metabolism, and that respiratory complex inhibitors like rotenone (for complex I) 
or azide (for complex IV) (173, 210) strongly impair oligodendrocytes differentiation. 
To further link mitochondrial impairment with oligodendrocytes differentiation we observed that 
exposure to a low concentration of a generic mitochondrial uncoupler, FCCP, was able to reproduce 
the reduction in ∆Ψm observed for TNFα, as also to reduce the amount of MBP+ and O4+ cells with 
concomitant accumulation of NG2+ positive cells. This gave strength to the hypothesis that the 
mitochondrial impairment exerted by TNFα is able to generate a block at an early stage of OPCs 
differentiation. 
The last point that we investigated was the correlation between OPCs differentiation and 
Ca2+signalling. It has been reported that the Sig-1R, a promoter of the Ca2+ transmission between 
mitochondria and ER, once overexpressed in glial primary cultures is able to induce spontaneous 
oligodendrocytes differentiation. Moreover, the calcium binding protein S100B is known to be able 
to interact with the mitochondrial protein ATAD3A and promote oligodendrocytes differentiation. 
Interestingly, this protein is also found to be located at the contact sites between mitochondria and 
ER. 
It is also well known how the purinergic mediator, ATP, is also able to promote oligodendrocytes 
differentiation, as also has been reported as and inducer of IP3R receptor opening, leading to 
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mitochondrial Ca2+ accumulation. Interestingly within the central nervous system TNFα is 
considered as an inhibitor of purinergic signalling (211).  
Thus, we found it of great interest to investigate this aspect, given that FCCP while reducing ∆Ψm is 
also able to block mitochondrial Ca2+ uptake it could be possible that in our experimental conditions 
FCCP was able to mimick TNFα not by exerting a metabolic impairment, but by reducing [Ca2+]m.  
To artificially increase [Ca2+]m we took advantage of the p38 MAPK inhibitor SB202190. This 
compound, differently from other MAPK inhibitors, is able to promote a rapid potentiation of 
mitochondrial Ca2+ uptake. Whether this effect is dependent on MAPK or not is still under debate. 
However, it is generally accepted that it could indirectly promote activity of the MCU. 
In our cell cultures SB202190 was able to recover [Ca2+]m in OPCs during TNFα exposure, but 
surprisingly completely reproduced the effect of TNFα causing an accumulation of NG2+ cells and 
reducing the amount of MBP+. Moreover, during a co-treatment we did not detect any synergistic 
effect, but the effect of TNFα appeared to be completely overcome. This suggests that [Ca2+]m has a 
special role in the differentiation process, but this role and its cooperation with the path of TNFα 
still remains unresolved. 
Summarizing the present study proposed that the TNFα is able to trigger two distinct cell 
fates in OPCs. One of blockage of differentiation, the other of induction of cell death. While 
impairing differentiation, TNFα induces a repression of mitochondrial physiology, through 
reducing the amount of Respiratory Complex I.  
 
Materials and Methods 
Reagents and solutions 
ATP, digitonin, H2O2, menadione (MEN), Adriamycin, α-Amanitin, Pifithrin were purchased from 
Sigma, coelenterazine from Molecular Probes, recombinant rat TNFα from Sigma-Aldrich.  
KRB contained: 125 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM Na2HPO4, 5.5 mM glucose, 
20 mM NaHCO3, 2 mM l-glutamine and 20 mM HEPES pH 7.4, and was supplemented with 1 mM 
CaCl2. 
 
Cells culture, transfection and detection of cell death  
Primary p53+/+ and p53-/- MEFs were prepared from embryos at day 13.5 of development (E13.5). 
Early passage (P2–P5) MEFs, grown in DMEM supplemented with 10% FCS, were used in all 
experiments. 
MEFs were transfected with different constructs using the MicroPorator (Digital Bio).  
HCT-116 were grown in McCOY supplemented with 10% FBS, 1% P/S and 1% L-Glutammine and 
 78 
transfected with a standard calcium-phosphate procedure 
HeLa and H1299 cells were grown in DMEM supplemented with 10% FCS and transfected with a 
standard calcium-phosphate procedure.  
MDA-MD 468 cells were grown in DMEM supplemented with 10% FCS and infected with 
adenovirus expressing a mitochondrial targeted aequorin chimera. 
Immoratlized MEFs Bax/Bak wt and DKO were grown in DMEM supplemented with 10% FCS 
and transfected with JetPEI Polyplus transfection kit according to the manufacturer protocol. 
MEF, HCT-116 and MDA-MD 468 cells were treated with Adriamycin 1 µM for 6 h, α-amanitin 
10 µg/ml for 6 h, pifithrin α 15 µM for 30 min. 
For cell death induction, cells were treated as indicated in the text with 1 mM H2O2, 15 µM MEN in 
DMEM supplemented with 10% FCS. 
Apoptosis was determined by FACS analysis of cells stained with Annexin-V FITC/Propidium 
Iodide (BioVision) or by TUNEL assay Click it, according to manufacturer protocol. 
 
Oligodendrocytes Progenitors Cultures generation 
Primary oligodendrocytes were prepared following the protocol of Chen et al., 2007. This method 
contemplates the generation of a population of oligodendrocytes precursor cell on a layer of 
astrocytes, originated by mixed glia cultures of P1-P2 pup rats. For the separating of the two kind of 
primary cell cultures, after 10 days of growth in DMEM 20% FBS, the whole preparation is 
exposed to sheer forces generated by its shaking on an orbital shaker at 190rpm. Collected 
oligodendrocytes progenitors are separated by residual microglia and astrocytes by incubation of 1h 
on uncoated petri dish, and then filtered in cell strainers with 40µM holes. Cell where then seeded 
on coverslip of different dimension, according with the planned experiment and kept in culture for 7 
days in chemically defined medium composed by DMEM, 4 mM L-glutamine, 1 mM sodium 
pyruvate, 0.1% BSA, 50 mg/ml Apo-transferrin, 5 mg/ml insulin, 30 nM sodium selenite, 10 nM D-
biotin and 10 nM hydrocortisone, 10 ng/ml PDGF-AA and 10 ng/ml bFGF. 
  
Generation of ER-p53 chimera expression vectors  
p53 was addressed to the external surface of ER by fusing sequence from the yeast UBC6 (162) 
protein  to the N-terminal end of the cDNA coding for the human p53-NLS. The chimera obtained, 
named ER-p53, was cloned in the pcDNA3 vector. 
 
Aequorin measurements 
Cells grown on 13 mm round glass coverslips at 50% confluence were transfected with the 
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appropriate chimera cyt, mt and erAEQ (as previously described (161)) alone or together with 
expression constructs ER-p53, p53 wt or p53-NLS.  
All aequorin measurements were carried out in KRB. Agonists and other drugs were added to the 
same medium, as specified in the figure legends. The experiments were terminated by lysing the 
cells with 100 µM digitonin in a hypotonic Ca2+-rich solution (10 mM CaCl2 in H2O), thus 
discharging the remaining aequorin pool. The light signal was collected and calibrated into [Ca2+] 
values, as previously described (161). 
 
Sub-cellular Fractionation  
Cells (109) were harvested, washed in phosphate- buffered saline medium, pelleted by 
centrifugation at 500 x g for 5 min, resuspended in homogenization buffer (0.25 M sucrose and 10 
mM Hepes pH 7.4) and gently disrupted by dounce homogenization. The homogenate was 
centrifuged twice at 600 x g for 5 min to remove cellular debris and nuclei, and the supernatant was 
centrifuged at 10.300 x g for 10 min to pellet crude mitochondria. The resultant supernatant was 
centrifuged at 100.000 x g for 1 h in a Beckman 70 Ti rotor at 40C to pellet microsomes, which 
were resuspended in homogenization buffer. The mitochondrial pellet, resuspended in isolation 
medium (250 mM mannitol, 5 mM Hepes (pH7.4), and 0.5 mM EGTA) was, layered on top of 8 ml 
of Percoll medium (225 mM mannitol, 25 mM Hepes (pH 7.4), 1 mM EGTA, and 30% Percoll 
(v/v) in a 10-ml polycarbonate ultracentrifuge tube and centrifuged for 30 min at 95.000 x g. A 
dense band containing purified mitochondria, recovered approximately ¾ down the tube, was 
removed, diluted with isolation medium, washed twice by centrifugation at 6.300 x g for 10 min to 
remove the Percoll, and finally resuspended in isolation medium. MAM, removed from the Percoll 
gradient as a diffuse white band located above the mitochondria, were diluted in isolation medium 
and centrifuged at 6.300 x g for 10 min. The supernatant containing MAM was centrifuged at 
100.000 x g for 1 h in a Beckman 70 Ti rotor, and the resulting pellet was resuspended in the 
homogenization buffer (41, 212). 
The quality of the preparation has been checked by western blot analysis using different markers for 
the fractions obtained.  
§ IP3R, as ER marker, should be present at about 20% in MAM fraction of than 
present in the ER.  
§ Voltage dependent anion channel (VDAC), as mitochondrial marker, should be 
present in Mc but must be enriched in Mp fraction. It should be also present in the MAM 
fraction.  
§ Tubulin, as cytosolic marker, should be absent in Mp, MAM and ER.  
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§ Laminin B, as nuclear marker, should be absent in Mp and MAM. 
 
Western Blotting  
30 µg of protein were separated by SDS-PAGE, transferred onto nitrocellulose membranes and 
probed using the following antibodies: anti-p53 (1:1000, Cell Signalling) for mouse cells, anti 
cleaved PARP (1:500 Cell Signalling) anti-IP3R-3 (1:500, BD-Pharmingen), anti-tubulin (1:5000, 
Santa Cruz), anti-Laminin (1:1000, abcam), anti-panVDAC (1:5000, abcam), anti-actin (1:3000, 
Santa Cruz), anti SERCA 2b (1:500, abcam), anti-OxPhos (1:1000, Mitoscience), anti-HSP60 
(1:1000, Santa Cruz). 
Isotype matched, horseradish peroxidase conjugated secondary antibodies were used followed by 
detection by chemiluminescence (Perkin Elmer). 
 
Immunolocalization 
Cells (MEFs, H1299, HCT-116, OPCs, Adult OLs) were fixed with 3.7% formaldehyde in PBS for 
20 min, washed three times with PBS and then incubated for 10 min in PBS supplemented with 50 
mM NH4Cl. Permeabilization of cell membranes was obtained with a 5 min incubation with 0.1% 
Triton X-100 in PBS, followed by a 1 h wash with 2% Non Fat Dry Milk in PBS. The cells were then 
incubated O/N at 37 °C in a wet chamber with the following antibodies: mouse anti-p53 DO-1 (Santa 
Cruz), goat anti-ACSL4 (FACL) N-18 (Santa Cruz) dilute 1:50 with 2% Milk in PBS or mouse anti-
NG2 (Santa Cruz), mouse anti-O4 (Sigma-Aldrich), mouse anti-MBP (Sigma-Aldrich), mouse anti-
OSP (Abcam) dilute 1:100. Staining was then carried out with Alexa 488 goat anti-mouse for p53, 
NG2, O4 and MBP, with Alexa 633 rabbit anti-goat for FACL, Alexa 594 goat anti-rabbit for OSP 
secondary antibodies. After each antibody incubation the cells were washed four times with PBS. 
Fluorescence was then analyzed with a widefield or confocal microscope.  
 
MBP Pull-down Assay 
p53 cDNA was cloned in pMAL protein fusion system (Biolabs). MBP-fused protein was expressed 
in E.Coli and was extracted in Column buffer (20 mM Tris-HCl pH7.5, 200 mM NaCl, 1 mM 
EDTA pH8, and 10 mM β-mercaptoethanol) and purified with amylose resin (NEB) following the 
manufacturer’s instructions. Cells were harvested in the in lysis buffer (20 mM Tris–HCl, pH 8.0, 
150 mM NaCl, 1 mM EDTA, 5% glycerol, 0.5% NP-40, 5 mM NaF, 1 mM Na3VO4 and a protease 
inhibitor cocktail). The cell lysate was incubated with 2.5 µg of MBP-p53 or MBP for 2 h then 
washed 3 times in lysis buffer. 
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Co-immunoprecipitation 
Extracts from MEFs wt were prepared using lysis buffer containing: 50 mM NaCl, 50 mM Tris-HCl 
pH 7.4, 0.1% NP-40 supplemented with 1 mM PMSF and proteases/phosphatases inhibitors. 
Protein extracts were pre-cleared with protein G/A beads (Pierce) than precipitated with rabbit anti-
p53 FL-393 (Santa Cruz) overnight at 4○C. Protein G beads were added and rocked 5 hours at 4○C. 
Afterwards, beads were washed with 50 mM NaCl, 50 mM Tris-HCl pH 7.4, 0.1% NP-40 4°C. 
Samples were proceed by SDS-PAGE and analyzed by standard western blotting technique.  
For the HAp53-SERCA 2b co-immunoprecipitation cells were lysed in Co-IP Buffer (50 mM Tris-
HCl pH 8, 150 mM NaCl, 1% NP-40, 10% glycerol) with protease inhibitor cocktail (Sigma), 1 
mM PMSF, 5 mM NaF, 1 mM Na3VO4, and 2mg of cleared lysates were then incubated for 2h 
with monoclonal anti-HA 12CA5 antibody covalently bound to protein G–Sepharose (Amersham) 
using 5mg/ml dimethylpimelimidate (Pierce). 
 
Mitochondrial morphology analysis 
MEF p53+/+or p53-/- and OPCs were seeded at 50.000 and 20000 cells for 25 mm coverslip 
respectively, let growth for 24 h and then infected with a GFP targeted to the mitochondria insert in 
an adenoviral vector (Ad-mtGFP). 36h expression cells were treated as described then imaged with 
a Nikon Swept Field confocal equipped with CFI Plan Apo VC60XH objective (N.A. 1.4) and an 
Andor DU885 EM-CCD camera. Coverslip where placed in an incubated chamber with controlled 
temperature, CO2 and humidity then z-stacks where acquired by 21 planes with 0.6 µm distance, to 
allow acquisition of the whole cell. Morphometric parameters where calculated on the best focused 
plane with NIS Elements (Nikon), while isosurface rendering and volume measurements were 
obtained with the 4D tools of MetaMorph (Universal Imaging). 
 
Automated nuclei count analysis  
MEF p53+/+or p53-/- were seeded at 50.000 cells for 25 mm coverslip, let growth for 48 h and then 
treated with ADRIA, H2O2 or both. Coverslips where stained with Hoechst 10 µM then placed in an 
incubated chamber with controlled temperature and mounted on an Axiovert 200M microscope 
equipped with a motorized stage. Nuclei were acquired with a 10x Fluar objective (Zeiss) and a  
CoolSnap HQ CCD camera. 20 random fields were acquired with the random stage scan tools in 
MetaMorph and analyzed with the Nuclei count application. 
 
High content throughput assay 
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OPCs culture where seeded on 96 well plates with glass bottom then after 7 days of cultures induce 
to differentiate substituting PDGF-AA and bFGF with 15 nM triiodothyronine for 5 days. Images 
where then acquired on Olympus Scan^R station, using a laser based hardware and an image based 
automatic autophocus. 80 field where acquired for each well using a 20x magnification, N.A. 0.75, 
while different fluorophores where exited by an MT20 illumination system and excitation filters 
used where 377/50, 498/20, 595/30 for DAPI, FITCH and TRITCH respectively allowing the 
shorter exposure time possible (5ms for Dapi, 20-50 for FITCH, 50-150 for TRITCH). Images 
where collected using an Orca-05G2 at full-frame, without binning. Cells where then scored and 
counted using the Scan^R analysis software. 
 
SERCA activity 
Analysis of SERCA activity was obtained on traces performed with an aequorin targeted to 
endoplasmic reticulum (erAEQ). Briefly time records from each single experiment were imported 
on Origin 6.0 and derivative was calculated. The first half of the filling phase was isolated and 5 
points around the maximum value were collected for average calculation. This value was used as 
indicator of the max speed of Ca2+ import into Endoplasmic Reticulum and proportional to SERCA 
activity or expression. 
 
Mitochondrial membrane potential measurements 
Mitochondrial membrane potential (∆Ψm) was measured using 10 nM tetramethyl rhodamine methyl 
ester (TMRM) on a confocal microscope (model LSM 510; Carl Zeiss MicroImaging, Inc.). FCCP 
(carbonyl cyanide p-trifluoromethoxyphenylhydrazone), to collapses mitochondrial ∆Ψ. The signal was 
collected as total emission >570 nm. 
 
ROS measurements 
Total release of ROS from mitochondria was estimated fluorimetrically by oxidation of 
Dihydroethidium, MitoSOX or DCF. Fluorescence was measured in multiwell plate reader (Infinite 
M200, Tecan, Austria) using 510 ± 10 nm excitation and 595 ± 35 nm emission wavelengths for 
MitoSOX and DHE while 513 ± 10 nm excitation and 530 ± 25 nm emission.  
 
 
Statistical analysis of data 
Statistical data are presented as mean ± S.D., significance was calculated by Student's t test, and 
correlation analysis was done with the SigmaPlot 5.0 software (SPSS Inc.). 
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